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Abstract

The Ten-eleven-translocation (TET) family of enzymes can oxidize the fifth base of DNA, 5-methylcytosine
(mC) sequentially, to 5-hydroxymethylcytosine (hmC), 5-formylcytosine (fC), and 5-carboxycytosine (caC).
The biochemical preference of TET enzymes for these substrates, in the canonical cytosine guanine
dinucleotides (CpG), mimics the order in which they are generated and is reflected in levels of these oxidized
modifications (oxmCs) detected in various genomes. Other than this exception, there is conflicting or limited
data concerning intrinsic substrate preferences of TET, particularly with regards to different nucleic acid
structures, sequence contexts, and extent to which TET mediates oxmCs in clustered proximity to one
another. Thus, in this thesis, I present our efforts to determine intrinsic substrate preferences of TET enzymes,
and in doing so expand upon our understanding of mechanisms driving these relative activities and the
functional significance of observed levels of oxmCs in vivo. After a review of the field, in Chapter 2, I present
our work comparing TET activity on different DNA and RNA structures in vitro. We found that TET is
relatively promiscuous on a variety of DNA/RNA structures but prefers DNA, a specificity that is dictated by
nucleic acid identity of the target base, as well helical conformation of the substrate. In Chapter 3, I newly
expose the relative tolerance of TET activity on hmC with a non-G at the +1 base, although mCpG is still
largely preferred. This tolerance for hmC oxidation by TET and fC and caC excision by TDG, regardless of
the +1 base, supports a model explaining hmCpH depletion relative to mCpH and hmCpG in some genomes.
In Chapter 4, I narrate our efforts to quantify clusters of oxmCs using modification-specific sequencing
methods and observe that TET is intrinsically capable of clusters of at least fC and caC. Also, we explore the
possibility that these clusters are mediated by either strand processivity of TET or underlying sequence
context preferences. Finally, I propose two kinetics-based experiments to test our hypotheses regarding
mechanisms driving these substrate preferences, along with ways to exploit our knowledge of TET enzymes
for creation of more efficient and specific epigenetic editing tools.
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ABSTRACT
NUCLEOBASE, NUCLEOSIDE, AND NEIGHBORING NUCLEOTIDES: INTRINSIC
PREFERENCES FOR TET ENZYME-MEDIATED OXIDATION OF 5-METHYLCYTOSINE
Jamie E. DeNizio
Rahul M. Kohli
The Ten-eleven-translocation (TET) family of enzymes can oxidize the fifth base of DNA,
5-methylcytosine (mC) sequentially, to 5-hydroxymethylcytosine (hmC), 5-formylcytosine (fC),
and 5-carboxycytosine (caC). The biochemical preference of TET enzymes for these substrates,
in the canonical cytosine guanine dinucleotides (CpG), mimics the order in which they are
generated and is reflected in levels of these oxidized modifications (oxmCs) detected in various
genomes. Other than this exception, there is conflicting or limited data concerning intrinsic
substrate preferences of TET, particularly with regards to different nucleic acid structures,
sequence contexts, and extent to which TET mediates oxmCs in clustered proximity to one
another. Thus, in this thesis, I present our efforts to determine intrinsic substrate preferences of
TET enzymes, and in doing so expand upon our understanding of mechanisms driving these
relative activities and the functional significance of observed levels of oxmCs in vivo. After a
review of the field, in Chapter 2, I present our work comparing TET activity on different DNA and
RNA structures in vitro. We found that TET is relatively promiscuous on a variety of DNA/RNA
structures but prefers DNA, a specificity that is dictated by nucleic acid identity of the target base,
as well helical conformation of the substrate. In Chapter 3, I newly expose the relative tolerance
of TET activity on hmC with a non-G at the +1 base, although mCpG is still largely preferred. This
tolerance for hmC oxidation by TET and fC and caC excision by TDG, regardless of the +1 base,
supports a model explaining hmCpH depletion relative to mCpH and hmCpG in some genomes.
In Chapter 4, I narrate our efforts to quantify clusters of oxmCs using modification-specific
sequencing methods and observe that TET is intrinsically capable of clusters of at least fC and
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caC. Also, we explore the possibility that these clusters are mediated by either strand processivity
of TET or underlying sequence context preferences. Finally, I propose two kinetics-based
experiments to test our hypotheses regarding mechanisms driving these substrate preferences,
along with ways to exploit our knowledge of TET enzymes for creation of more efficient and
specific epigenetic editing tools.
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CHAPTER 1: Introduction
Portions of this chapter have been adapted from:
Liu, M.Y., DeNizio, J.E., Schutsky, E.K., Kohli, R.M. The expanding scope and impact of
epigenetic cytosine modifications. Curr. Opin. Chem. Biol. 2016, 33, 67-73.
1.1: Epigenetic cytosine modifications
1.1.1: 5-methylcytosine, the fifth base of DNA
In a single cell, there are more than 6 billion deoxyribonucleotides. Simultaneously, there
can be as much as 8X more RNA material. In this congested milieu of information-carrying
molecules, epigenetic modifications provide an instruction manual to ensure the reliable
interpretation of the genetic code. In eukaryotes, covalent modifications of DNA are a critical
component of this regime. The prototypical modification, 5-methylcytosine (mC), is broadly
conserved in species ranging from vertebrates to fungi and protists and is considered the fifth
base of DNA (Smith and Meissner, 2013). It is considered an epigenetic mark both because it
does not alter the Watson-Crick base-pairing of cytosine and because it can be heritable across
cell generations.
DNA has been shown to be methylated at the 5-position of cytosine in both cytosineguanine dinucleotides (CpGs) and CpH (H=A,G,T) sequence contexts. Each CpH dinucleotide
makes up roughly 4% of the genome, as expected by probability. Although CpH methylation
(mCpH) has been detected at as much as 2-6% of CpHs in embryonic stem cells (ESCs) and
neurons (Jang et al., 2017), it is sparse in differentiated cells. In contrast, CpGs are relatively
depleted in vertebrate genomes, accounting for less than 1% of dinucleotides, but 60-80% of
these CpGs are methylated. The reduction of CpGs is due to the high rate of spontaneous
deamination of mC, which results in a G•T mismatch (Bird, A. P., 1980; Cooper and Youssoufian,
1988; Shen, J. C. et al., 1994). Unlike spontaneous C deamination, which results in a uracil that is
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quickly repaired via base excision repair (BER), G•T mismatches are often erroneously resolved
to A•T (Bellacosa and Drohat, 2015). Interestingly, CpGs tend to occur in clusters, primarily in
regions termed CpG Islands (CGIs), which are CpG-dense regions typically devoid of mC that
occur in or near 70% of promoters in vertebrates (Deaton and Bird, 2011).
The presence of cytosine methylation is primarily associated with transcriptional
repression. In particular, methylation of CGIs near promoters often results in gene silencing due
to impaired transcription factor binding or the recruitment of other proteins such as histone
modifiers that are thought to promote a closed, repressive chromatin state (Deaton and Bird,
2011). There have been a couple instances in which a single mCpG site has been implicated in
affecting transcription, both in an imprinting (Choi et al., 2018) and cell-type specific manner
(Furst et al., 2012). However, in general, impactful changes in methylation occur at multiple
CpGs. When these regions exist with different methylation statues among multiple samples, such
as in different states of development, various cell types, or diseased versus healthy tissues, these
regions are formally considered Differentially Methylated Regions (DMRs).
Although most commonly considered a repressive mark, the downstream effect of
methylation can vary depending on the biological context. For example, there is loci-specific
variation of whether the methylation state acts as the catalyst for or a component of silencing
(Schubeler, 2015). Meanwhile, non-methylated CGIs have also been associated with inactive
genes, and mCpGs have also been shown to exist in activating transcription regulatory regions.
CpG methylation has also been identified in intergenic DNA, exons of genes, and satellite DNA,
but the role of methylation in these regions is still somewhat undefined. The function of CpH
methylation has been shown to be similarly variable. mCpHs can cause transcriptional repression
in vitro, as well as in mouse neurons (Guo et al., 2014). In contrast, actively transcribed genes in
neurons tend to lack mCpH (Lister et al., 2013), while those actively transcribed in ESCs tend to
be hyper-methylated at CpHs (Lister et al., 2009).
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Regardless of the downstream effects on transcription, the symmetrical nature of CpG
dinucleotides allows for the stable inheritance of the relative methylation statuses. While
methylation is primarily established during embryonic development by DNA methyltransferase
(DNMT) 3a/3b, irrespective of opposite strand methylation, it is maintained after cell division by
DNMT1, which specifically copies mC, converting hemi-methylated DNA after replication to
symmetrically methylated DNA (Jurkowska et al., 2011). This mechanism of maintenance,
allowing for epigenetic “memory,” results in the long-term stability of methylation patterns, which
are important for maintaining cell fates, tumor suppression, silencing retrotransposons, Xchromosome inactivation, and establishing genomic imprinting (Bird, A., 2011; Dor and Cedar,
2018). While both DNMT1 and DNMT3a/3b exhibit greater activity for CpG sites, DNMT3a/b are
considered to be solely responsible for both the establishment and maintenance of mCpH in vivo,
as DNMT1-specific methylation has been shown to localize only to CpGs (Guo et al., 2014).
In addition to DNA, cytosine methylation has also been detected in different nucleic acid
structures. 5-methylcytosine in RNA is much less prevalent, accounting for only at most 1% of
cytosines in RNA, but has been identified in several kinds of RNA, including mRNA, tRNA, rfRNA,
and ncRNA (Huang, W. et al., 2016; Motorin et al., 2010; Squires et al., 2012). Also, unique RNA
methyltransferases, NSun2 and DNMT2, have been identified and characterized (Bohnsack et al.,
2019). Although the functional role of mC in RNA remains largely unclear, there is evidence that it
plays a role in nuclear transport and enhancing mRNA translation. Further, deletion of the RNA
methyltransferase NSun2 has been shown to impair cellular differentiation pathways and is
associated with neurological deficiencies in mammals (Sanchez-Vasquez et al., 2018).
1.1.2: Pathways of cytosine demethylation
Just as there is a biological need for methylation, there is a requirement for the need for
the removal of DNA methylation, or DNA demethylation, as well. There are two methods by which
DNA demethylation, i.e. the ultimate removal of the 5-methyl group, can occur. First, DNA
3

replication can lead to a passive reduction in methylation when the maintenance activity of
DNMT1 is diminished or inhibited; the mC signal is diluted over time upon sequential replications.
This can occur for mCpGs, but as mentioned above, it likely occurs on a more significant scale for
mCpHs due to DNMT1 discrimination. In addition to this passive, temporally-dependent
mechanism, evidence in germ cells and early embryos dictate that an active mechanism must
also exist for rapid, regulated demethylation (Kohli and Zhang, 2013). In plants, there are a family
of DNA glycosylases, Repressor of Silencing 1 (ROS1)/DEMETER (DME), that can excise mC
directly (Gong et al. 2002; Jang et al. 2014; Hong et al. 2014). In the absence of a similar enzyme
in mammals, several indirect avenues for demethylation have been hypothesized. At one point,
there was strong interest in the possibility that demethylation could occur after repair of
deamination of mC. It was proposed that the AID/APOBEC family of enzymes, known for
deaminating cytosine, could deaminate mC to thymine for excision by thymine DNA glycosylase
(TDG) or methyl-binding domain protein 4 (MBD4), followed by base excision repair (BER) to
reintroduce unmodified cytosine (Rai et al., 2008; Bhutani et al., Nature 2010; Cortellino et al.,
2011). Although our lab has recently shown that at least one family member, APOBEC3A, is
capable of efficiently deaminating mC (Schutsky et al., 2017), other family members have poor
activity on mC (Nabel et al., 2012). Further, the AID/APOBEC family, in general, have strong
sequence preferences in single-stranded DNA (Ito, F. et al., 2017), making this pathway an
unlikely candidate for the full extent of demethylation observed.
Ten-eleven translocation (TET) family of enzymes, which are Fe(II)/α-ketoglutarate (αKG)-dependent dioxygenases, and are now considered one of the major players of active
demethylation. The three mammalian TET homologs (TET1, 2, 3) were initially found to oxidize
mC to 5-hydroxymethylcytosine (hmC) (Ito, S. et al., 2010; Tahiliani et al., 2009). Later
discoveries revealed TET enzymes could sequentially oxidize hmC to 5-formylcytosine (fC) and
5-carboxylcytosine (caC) (He, Y. F. et al., 2011; Ito, S. et al., 2011; Pfaffeneder et al., 2011)
4

(Figure 1-1). The conversion of mC to the oxidized bases (collectively referred to as oxmCs), fC
and caC in particular, is thought to invoke passive demethylation upon replication as DNMT1 is
largely inhibited from methylating opposite oxmCs (Hashimoto et al., 2012; Ji et al., 2014; Seiler
et al., 2018). However, proposing a role for passive demethylation in any step of the pathway
would not account for the rate at which demethylation occurs in germ cells and embryonic cells.
Currently, the most compelling model for active demethylation involves the oxidation of mC to fC
or caC by TET, base excision of fC and caC by TDG, followed by BER to regenerate unmodified
cytosine (Chen, H. et al., 2014; He, Y. F. et al., 2011) (Figure 1-1). In support of this model, TDG
knockout mice exhibit higher levels of 5mC (Cortazar et al., 2011; Cortellino et al., 2011), and the
overexpression of TDG in HEK293 cells causes lower levels of fC (Nabel et al., 2012) and caC
(He, Y. F. et al., 2011). In addition, this pathway has been reconstituted in vitro (Weber et al.,
2016). Notably, it has not been explored whether active demethylation occurs at CpHs or in other
likely TET substrates, such as RNA.

Figure 1-1. TET oxidation is involved in two possible pathways for cytosine
demethylation.
DNMTs transfer a methyl group to the 5-position of cytosine. TET enzymes are
capable of sequentially oxidizing mC to either hmC, fC, or caC. All four modified
cytosine bases can be passively demethylated after replication due to
maintenance failure or inhibition. Only fC and caC are possible intermediates for
active demethylation, as they are excised by TDG, then ultimately replaced with
unmodified cytosine via base excision repair.
5

1.1.3: Stability of oxmCs in epigenome
The bases resulting from TET oxidation are not merely transient intermediates in
demethylation but have been stably mapped in many cell lines (Booth et al., 2015; Wu, H. and
Zhang, 2015). In some cell types, 5hmC can account for 1-10% of 5mC, depending on the
sequencing methodology, with levels of ~10% reported in ESCs and as high as 40% in Purkinje
neurons (Globisch et al., 2010). The higher order modifications, fC and caC, are also stably
detected; however, they are found at levels at least 10-fold lower than hmC— approximately 1 in
105–106 nucleotides. In general, oxmCs are generally considered activating marks, as they are
enriched in active enhancers and other regulatory regions.
This observed stability detected by sequencing localization begs the question whether
these modifications are maintained after replication, like mC, or independently re-established via
an alternate mechanism. Isotopic labeling experiments support potentially long-lived modifications
(Bachman et al., 2014; Bachman et al., 2015). Despite the necessity for mC to act as a precursor,
it seems unlikely that the maintenance of oxmCs occurs through the same mechanisms as mC.
First, it would require targeted methylation across from an oxidized base, which is unlikely as
DNMT1 has been shown to be very inefficient at methylating opposite an oxmC (Hashimoto et al.,
2012; Ji et al., 2014; Seiler et al., 2018). Second, a TET enzyme would be required to both
recognize the existing oxmC and the mC in the CpG•CpG pairs to generate the same base
across from it. In addition, single-molecule fluorescent labeling of both mC and hmC indicated
that hmC frequently occurs opposite mC in CpG nucleotide pairs and that dually
hydroxymethylated CpG•CpG base pairs are rare (Song, C. X. et al., 2016). In agreement with
this observation, in vitro work within our lab showed that mouse TET2 has de novo activity
6

(Crawford et al., 2016), oxidizing independently of the identity of the opposite strand CpG.
However, it remains unclear if other TET homologs have maintenance activity.
1.2: Functional epigenetic roles of oxmCs
1.2.1: Chemical effects of oxmCs
There are still many important questions remaining concerning how oxmCs are
generated. That said, it is helpful to understand the functional consequences of these
modifications on gene expression when considering where and when TET may be regulated to
mediate these marks. For example, there is some evidence that oxmCs themselves can directly
impact transcription. Ox-mCs form high-fidelity, Watson-Crick base pairs with guanine and are
generally not prone to spontaneous deamination and oxidation events (Renciuk et al., 2013;
Schiesser et al., 2013). The 5-modified group occupies the major groove of B-form DNA and
appears to have a subtle but potentially significant impact on helical thermodynamics and stability
(Renciuk et al., 2013; Szulik et al., 2015). For example, the electron-withdrawing character of 5formyl and 5-carboxyl groups weakens the N-glycosidic bond and decreases the pKa of the base,
resulting in less stable base pairing and possibly promoting base excision by TDG (Dai et al.,
2016; Maiti et al., 2013). Also, DNA containing as few as one fC or two hmC displayed greater
flexibility in a single-molecule cyclization assay, and this flexibility correlated with enhanced
nucleosome stability (Ngo et al., 2016). However, hmC-containing DNA has also been shown to
have increased binding affinity to the histone core but ultimately results in looser chromatin
packing due to the weakened interaction between hmC and the H2A-H2B dimer (Mendonca et
al., 2014). In support of this potential effect of oxmCs, looser chromatin packing has been shown
to correlate with high levels of hmC (Mahe et al., 2017).
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1.2.2: Protein readers of oxmCs
Overall, however, the evidence suggests that 5-modification of cytosines largely
maintains the structural and sequence integrity of DNA while providing an accessible handle for
epigenetic readouts. Through proteomic analyses, several oxmC-specific reader proteins have
been identified (Chen, C. C. et al., 2012; Liutkeviciute et al., 2009; Spruijt et al., 2013).
Transcription factors have been one area of focus; for example, methyl-CpG-binding protein 2
(MeCP2) was identified as a major hmC-binding protein in the brain, with similar affinity for mC
and hmC (Iurlaro et al., 2013), while Wilms tumor protein 1 (WT1) can recognize caC as well as C
and mC (Hashimoto, Olanrewaju et al., 2014; Spruijt et al., 2013). The yeast RNA polymerase II
elongation complex was reported to form hydrogen bonds specifically with caC, resulting in
transient transcriptional pausing (Kellinger et al., 2012; Wang, L. et al., 2015). Also, through
altered CTCF binding, the identity of the modified cytosine has been shown to dictate splicing by
affecting the rate of RNA polymerization: The presence of mC at a CTCF site resulted in
exclusion of an exon while an hmC or caC caused exon inclusion (Shukla et al., 2011).
Thus, there is evidence to suggest both that oxmCs themselves can play a role in gene
regulation and that they can be read by proteins that affect transcription downstream. The
mechanisms discussed in this section are likely more significant for stable oxmCs, but even the
transient presence of these modifications may elicit similar effects temporarily. Regardless, it
appears that the signature of oxmCs is very context-specific. Understanding the scope of TET
reactivity, and further, how TET is intrinsically tuned to regulate this activity, can potentially help
us link context and phenotype to function.
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1.3: Scope of TET reactivity
There are several layers to the regulation of the catalytic activity of TET enzymes (Figure
1-2). While they are all undoubtedly interconnected, it is informative to discuss them as discreet
reactivities. From a wide lens in, they are as follows: type of nucleic acid (DNA versus RNA,
Chapter 2), sequence context (CpG versus CpH, Chapter 3), C versus T, and modified 5-position
preference. In the following section, I will discuss what we know about these levels of reactivity
from the biological contexts in which TET homologs and oxmCs occur and previous structural and
biochemical data.

Figure 1-2. Summary cartoon of factors influencing TET reactivity.
1.3.1: External factors influencing TET reactivity
Prior to discussing the intrinsic factors that influence TET oxidation, it is important to
highlight the external factors that can dictate TET reactivity, such as post-translational
modifications (PTMs), protein recruitment, and chromatin accessibility. PTMs have been shown to
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affect localization and chromatin binding (Wu, X. and Zhang, 2017). Several PTMS have also
been demonstrated to alter the enzymatic activity of TET enzymes. For example, acetylation of
two N-terminal lysine residues of TET2 enhances activity and stabilizes the protein (Zhang, Y. et
al., 2017). O-GlcNAcylation stimulates the activity of TET1 to a greater extent than the OGT-TET
interaction alone (Hrit et al., 2017). TET is also the target of both covalent and noncovalent
PARylation; while the former is stimulating, the latter decreases the catalytic activity of TET
(Ciccarone et al., 2015). There has also been some evidence that metabolic pathways can
influence TET activity via modification of the TET protein: In starvation conditions, it has been
shown that AMP-activated kinase phosphorylates TET2 residue S99. Along with the finding that
TET2 in cells cultured in high-glucose media exhibit a reduced half-life, it is proposed that S99
phosphorylation protects TET2 from degradation (Wu, D. et al., 2018).
Although a classic chaperone has not been identified, the TET enzymes do interact with
a variety of proteins (Spruijt et al., 2013), a number of which have been shown to aid in recruiting
TET to specific loci. For example, several transcription factors, including NANOG, PU.1, and
WT1, have been shown to recruit TET to their target genes to enhance the efficiency of
reprogramming, ensure monocyte-to-osteoclast differentiation, and suppress acute myeloid
leukemia (AML), respectively (Costa et al., Nature 2013; de la Rica et al., Genome Biol 2013;
Wang et al., Mol Cell 2015). It has also been proposed that Lin 28, which binds both ssDNA and
RNA, binds active transcriptional bubbles, and recruits TET1 to certain loci to generate hmC
(Zeng et al., 2016). However, no direct protein interaction was shown. TET2 has also been shown
to be recruited to specific promoters by co-activator SMAD nuclear interacting protein 1 (SNIP1),

10

which also facilitates the interaction of TET2 with many different sequence-specific DNA-binding
factors (Chen, L. et al., 2018).
The level of chromatin compaction is also proposed to affect both TET activity and the
capacity for active demethylation. In in vitro assays using reconstituted nucleosomes, TET1
prefers the linker region rather than the histone core (Kizaki, Seiichiro, Zou et al., 2016). With
regards to the capacity for demethylation, TDG activity has also been shown to be inhibited to
some extent by the nucleosome histone core; while both U and T can be excised from a
nucleosome core particle at the wobble base pair in dyad region, there is still some proportion
that is inaccessible to cleavage, either due to inhibition of the base extrusion or TDG intercalation,
or inhibition of initial TDG binding (Tarantino et al., 2018). However, fC- and caC- containing
nucleosomes have not been tested.

1.3.2: Biological contexts of TET enzymes
The biological contexts where TET homologues and oxmCs are found can be informative
of both the substrate and sequence determinants of TET enzymes (Figure 1-2). Computational
studies have mapped a large family of TET-related proteins spanning the evolutionary tree (Iyer
et al., 2013). Some species harbor a bewildering number of TET homologues—47 in the fungus
C. cinerea, many catalytically active and associated with transposons (Iyer et al., 2014; Zhang, L.
et al., 2014). There is also a TET homologue in D. melanogaster (DmTET), but interestingly, mC
is absent from genomic DNA but present in RNA, along with oxmCs (Delatte et al., 2016; Fu et
al., 2014). It is untested whether DmTET lacks activity on deoxyribomethylcytosine or if the
absence of this substrate in the fly genome obscures this possible activity. Further, it is unclear
what the comparative activity levels of DmTET versus mammalian TET homologs are on RNA.
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On the other hand, oxidized RNA bases are detected in Tet-null embryonic stem cells (Fu et al.,
2014), as well as in organisms that lack TET homologues (Huber et al., 2015), indicating that
TET-independent mechanisms could contribute.

Figure 1-3. The broad scope of TET reactivity.
Summary of the generation of various nucleobases (top row) in both DNA and
RNA (middle) of diverse species (bottom), with emphasis on the strongest
exemplar (underlined). Canonically, TET enzymes iteratively oxidize mC in
dsDNA to hmC, fC, and caC, with decreasing reactivity on more highly oxidized
substrates. In addition, mC, hmC, and fC have been detected in RNA, with
evidence for TET-dependent oxidation, as well as potential alternative
mechanisms. Finally, TET enzymes can, to a limited extent, convert T to hmU in
DNA, similar to the well-known JBP1/2 enzymes in Trypanosoma.
Analyzing different TET homologs can also highlight whether substrate specificities are
varied or conserved. For example, the preference for CpGs in DNA is conserved between
mammalian TET homologs and Naegleria gruberi TET1 (NgTET1) (Pais et al., 2015). In contrast,
human TET2 has been previously shown to have minimal activity on mCpHs (Hu, L. et al., 2013),
while NgTET1 has robust activity on certain modified CpHs in vitro (Pais et al., 2015). Several of
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the TET homologs also display differential activity on cytosine versus thymine. Several
dioxygenases in the Fe(II)/αKG-dependent family, such as the trypanosomal J-binding proteins
(JBP1 and JBP2), naturally hydroxylate thymine, resulting in 5-hydroxymethyluracil (hmU), rather
than cytosine (Cliffe et al., 2009). NgTET1 can also oxidize thymine in vitro but has at about 30fold less activity on T compared to mC (Pais et al., 2015). Meanwhile, mammalian TET enzymes
have very limited activity on thymine both in vivo, via the detection of hmU in cells (Pfaffeneder et
al., 2014), and in vitro (Pais et al., 2015). Shared between all species is the preference for
oxidizing mC over the other two substrates, hmC and fC. Although it will be discussed further in
subsection 1.3.4, this shared preference likely occurs because the key TET residues responsible
are largely conserved across the phylogenetic tree.
The human TET homologs are arguably the best-characterized among the enzyme family
and comparing the different targeting domains in both the full-length and truncated isoforms can
illuminate TET’s intrinsic localization mechanisms. First, it should be noted that the human TET
homologs (TET1-3) are expressed differentially across development, as well as in different
tissues. For example, TET1 and TET2 are expressed in embryonic stem (ES) cells, while TET2
and TET3 are found in most differentiated cells. Sequencing studies of TET knockdown tissue or
cell lines have shown that the different TET enzymes have both overlapping and distinct targets
in the genome. Further, both TET1 and TET3 also have truncated isoforms with unique
expression profiles and potentially unique biological functions (Melamed et al., 2018).
Some of the different biological functions of the different mammalian homologs and
isoforms could be due to the presence or absence of a Cys-X-X-Cys (CXXC) domain, historically
known for binding unmethylated CpGs, particularly in CGIs. It is thought that this domain targets
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TETs to CGIs in order to assist in the maintenance of the unmethylated state, by oxidizing,
excising, and repairing any mC that may erroneously arise; however, there is no direct evidence
to support this. The full-length isoform of TET2 lacks a CXXC domain while TET1 and TET3 both
have CXXC domains in their non-catalytic, N-terminal domains. Interestingly, while the CXXC
domain of TET3 binds to unmethylated CpGs, it binds most strongly to caCpGs (Jin et al., 2016).
TET2, which has been identified only as a single isoform and does not have a CXXC domain, has
been shown to interact with the CXXC-containing protein IDAX (Ko et al., 2013). Similarly, the
truncated isoforms of TET1 and TET3 all lack CXXC domains and have been shown to utilize
other protein interactions for altered DNA targeting (Melamed et al., 2018). Although TET may
have an intrinsic targeting mechanism via the CXXC domain, we know that mC oxidation occurs
in regions other than CGIs, so there are likely many other factors contributing to its localization.
1.3.4: Structural and biochemical evidence of specificities regulating TET activity
TET enzymes, Fe(II)/α-ketoglutarate (α-KG)-dependent dioxygenases, are generally
accepted to act via generation of a reactive Fe(IV)-oxo intermediate, driving proton abstraction
and subsequent rearrangements that result in oxidation of the 5-position of cytosine and
regeneration of Fe(II) (Figure 1-3) (Lu, Zhao & He, Chem Rev 2015). The original crystal
structure was solved using a variant of the catalytic domain of TET2 in complex with mCcontaining duplex DNA (Hu, L. et al., 2013). At the same time, a similar structure of NgTET1 was
also solved (Hashimoto, Pais et al., 2014). In both structures, TET forms a compact globular
structure in which a double-stranded beta helix (DSBH) core is surrounded by a Cys-rich domain
on both sides. The DNA sits above the DSBH core, packing into a shallow groove formed by two
loops from a Cys-subdomain, one of which forms a hydrophobic ridge and inserts into the minor
groove. The target mC is flipped out of the DNA helix into a cavity of TET, in proximity to the
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necessary cofactors. In agreement with these structures, it has been shown that only the Cterminal catalytic domain of of the enzyme is necessary for oxidation both in vitro and in vivo (Hu,
L. et al., 2013).

Figure 1-4. Scheme of proposed catalytic reaction steps of TET enzymes.
(I) TET harnesses electrons from Fe(II) and coordinated α-ketoglutarate (αKG) to
split molecular oxygen (O2), while αKG undergoes oxidative decarboxylation
resulting in succinate and a Fe(IV)-oxo intermediate (II) This intermediate
activates the target C-H bond of mC for oxidation, resulting in hmC and
regenerated Fe(II) (III) (Lu et al., 2015).
In the active site of the structure with human TET2, the 5-methyl group, which has no
direct contacts with TET, is positioned towards N-oxalylglycine (NOG, an inactive analog of αKG)
and Fe(II), primed for catalysis (Hu, L. et al., 2013). Importantly, there is steric availability
surrounding the 5-methyl group to allow for larger chemical groups 1. Likely responsible for both
the specific recognition of cytosine and positioning the base for catalysis, the endocyclic nitrogen
atoms N3 and N4 of the mC base form two hydrogen bonds with residues H1904 and N1387,

1

Our lab exploited the observed space surrounding the methyl group to develop activity-based probes in Ghanty et al.,
JACS 2018.
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respectively. Also, TET residue Y1902 forms a base-stacking interaction with mC. Previous work
from our lab identified that Y1902 along with T1372 comprise an active site scaffold that is
essential for catalysis (Liu, M. Y. et al., 2017). We also found that mutating T1372 to E/Q/N/D/V
effectively halted oxidation at hmC, while having no effect DNA-binding affinity.
Two years after the initial crystal structures, the same groups solved the structures of
either TET2-CS or NgTET1 in complex with hmC- and fC-containing DNA (Hashimoto et al.,
2015; Hu, L. et al., 2015). In general, the structures were very similar to the one containing mC
and did not provide an immediate explanation for the observed difference in TET activity on mC
compared to hmC. As a result of applying molecular dynamic simulations to the three structures
containing each of the oxmCs, He et al. concluded that the rate-limiting hydrogen abstraction step
in the TET2-containing complex results in slower decay of the ferryl-oxo intermediate with hmC
and fC compared to mC (Hu, L. et al., 2015). In line with this observation, all TET enzymes to
date exhibit a catalytic preference for mC over hmC and hmC over fC (Hashimoto et al., 2015; Ito,
S. et al., 2011; Pfaffeneder et al., 2011). Despite having similar binding affinities, hTET2
displayed a ~2-5-fold difference in kcat and Km for mC over the other substrate bases (Hu, L. et al.,
2015).
In addition to the relative preference for the three substrate bases, an important initial
question in the field was whether the TET enzymes are capable of iterative oxidation, or catalytic
processivity—that is, whether TET is capable of generating fC and caC from a mC substrate
without fully releasing the hmC intermediate. The crystal structure of TET2 indicates that some
conformational change must occur after catalysis to allow for exchange of fresh cofactors, but
that does not exclude the possibility that TET remains either specifically or non-specifically bound
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to DNA (Crawford et al., 2016). To test whether TET can act iteratively, our lab performed highly
sensitive isotope-based experiments and found that mouse TET2 can generate fC and caC from
a single encounter with mC-containing DNA, without releasing hmC prior to doing so (Crawford et
al., 2016). In contrast, another group has proposed that TET is distributive, meaning it randomly
catalyzes individual turnover events. Further, they also called our experimental approach into
question (Tamanaha et al., 2016), but we would also argue that their conditions favored
distributive behavior. Nevertheless, iterative oxidation provides a mechanism for the efficient
production of highly oxidized fC and caC bases, which could encode distinct epigenetic functions.
However, it remains possible that not at all fC and caC are generated in this manner.
Several other possible determining factors of TET’s substrate preferences, such as
nucleic acid identity, substrate secondary structure, and sequence context, are not readily clear
from the crystal structure data alone. First, the majority of TET contacts with the target strand
other than those with the cytosine base are with the phosphodiester backbone and there appears
to be sufficient room surrounding the 2’-position of the sugar to accommodate a hydroxyl group
(Hu, L. et al., 2013). Thus, despite a relatively greater abundance of oxmCs in DNA compared to
RNA, the structural data supports relative promiscuity for different nucleic acids.
Next, if we examine the contacts that TET makes with the opposite strand of DNA in the
crystal structure, we observe that TET2 residue Y1294 is inserted into where the guanine of the
target mC•G base pair would occur in a conventional B-form helix (Hu, L. et al., 2013). The
authors of the study proposed that the Y1294 and M1293 push out this guanine, breaking its
base-stacking interactions, allowing mC to break its Watson-Crick base pair and flip out of the
DNA helix and into the active site of TET. However, in Chapters 2-4, we provide evidence that
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TET is biochemically active on single-stranded DNA, suggesting that this displacement of
guanine is not essential for the engagement of the target base, although it is possible that it
provides a stabilizing effect. Nevertheless, a pathological mutation of one of the residues that
forms this hydrophobic ridge, W1291R, has been shown to result in a loss of activity in vitro,
reaffirming the importance of the positioning of this loop.
Finally, Y1294 has also been implicated as critical for CpG recognition, as it forms a
base-stacking interaction with the opposite strand mC, which base pairs with the +1 guanine (Hu,
L. et al., 2013). To test this, the authors assessed the activity of a double-mutant TET2 variant
with Y1294A and M1293A and observed significantly diminished catalytic activity in vitro. Notably,
however, the authors do not perform biochemical analysis on CpG or any of the CpH contexts
with this TET2 variant or that with the single Y1294A mutation.

1.3.5 Intrinsic ability of TET to catalyze clusters of oxmCs
In addition to the efforts to catalog and expose the substrate preferences intrinsic to TET
and the underlying mechanisms regulating this specificity, there is a need within the field to
understand TET activity in the presence of multiple target sites on a single DNA molecule. As
mentioned previously, most transcriptionally activating events of TET activity occur from the
oxidation (or full demethylation pathway) of multiple CpGs. Thus, in Chapter 4, we investigate
whether TET has the propensity to catalyze multiple reactions in clusters. One way in which this
could occur is if TET were intrinsically strand processive; that is, if TET is capable of catalyzing
sequential reactions on a single strand of DNA without releasing the substrate. In the crystal
structure of hTET2, there are several sequence-non-specific contacts between positively charged
and polar residues of TET and the phosphodiester backbone of the target strand of DNA that
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support the notion that TET may be capable of loosely maintaining these interactions and sliding
along DNA (Hu, L. et al., 2013), exhibiting strand processivity between potential target sites.
Likely due to the challenging nature of addressing this question, only one group has asked
whether TET enzymes can act processively. Although they proposed that several TET homologs
do not exhibit strand processivity, we do not believe their experimental design was set up to
adequately to test this (Tamanaha et al., 2016). Thus, in Chapter 4, we also set out to tackle the
question of whether TET can act in a processive manner on a strand of DNA.
1.4: Thesis Objectives
The reductionist power of biochemistry allows us to remove the multitude of factors
involved in the full pathways of epigenetic regulation. This dissertation aims to exploit a pareddown environment to ask solely about the influence of the intrinsic properties of TET on its
observed activities. In Chapter 2, we combine biochemistry with molecular modeling to define the
substrate preferences of human TET enzymes for DNA, RNA, and DNA:RNA hybrids. In addition,
we identify the strongest determinant for these relative preferences and provide a possible
structural and thermodynamic mechanistic explanation. In Chapter 3, we performed rigorous
biochemistry with both TET and TDG on substrates containing each of the three possible
substrate bases (mC, hmC, fC) in either a CpG or CpH sequence context. Our findings allow us
to propose a model for the biological observation of why there is not a proportionate amount of
hmCpH in cells with higher levels of mCpH. In Chapter 4, we use BS-seq to localize TETgenerated higher order oxmCs (hoxmCs, fC and caC) on DNA that initially had all mCpGs to
quantify TET enzymes’ ability to modify DNA in clusters. Further, we test whether intrinsic
processivity of the enzyme is a possible mechanism for this activity. Overall, this dissertation
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contributes to our understanding of the biochemical basis for the patterns of oxmCs found in the
genome.
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CHAPTER 2: Selectivity and Promiscuity in TET-mediated oxidation of 5-methylcytosine in
DNA and RNA
This chapter has been adapted from the following manuscript:
DeNizio, J.E. 2, Liu, M.Y.2, Leddin, E.M., Cisneros, G.A., Kohli, R.M. Selectivity and
Promiscuity in TET-Mediated Oxidation of 5-Methylcytosine. Biochemistry 2019, 58, 411-421.
2.1: Abstract
Enzymes of the ten-eleven translocation (TET) family add diversity to the repertoire of
nucleobase modifications by catalyzing the oxidation of 5-methylcytosine (5mC). TET enzymes
were initially found to oxidize 5-methyl-2’-deoxycytidine in genomic DNA, yielding products that
contribute to epigenetic regulation in mammalian cells, but have since been found to also oxidize
5-methylcytidine in RNA. Considering the different configurations of single- and double-stranded
DNA and RNA that co-exist in a cell, defining the scope of TET’s preferred activity and the
mechanisms of substrate selectivity is critical to better understand the enzymes’ biological
functions. To this end, we have systematically examined the activity of human TET2 on DNA,
RNA, and hybrid substrates in vitro. We found that, while ssDNA and ssRNA are well tolerated,
TET2 is most proficient at dsDNA oxidation and discriminates strongly against dsRNA. Chimeric
and hybrid substrates containing mixed DNA and RNA character helped reveal two main features
by which the enzyme discriminates between substrates. First, the identity of the target nucleotide
alone is the strongest reactivity determinant, with a preference for 5-methyldeoxycytidine, while
both DNA or RNA are relatively tolerated on the rest of the target strand. Second, while a
complementary strand is not required for activity, DNA is the preferred partner, and
complementary RNA diminishes reactivity. Our biochemical analysis, complemented by molecular
dynamics simulations, provides support for an active site optimally configured for dsDNA
reactivity but permissive for various nucleic acid configurations, suggesting a broad range of
plausible roles for TET-mediated 5mC oxidation in cells.

2

These authors contributed equally to this work.

21

2.2: Introduction
Long thought to be the only significant DNA modification in mammalian genomes, 5methyl-2’-deoxycytidine (5mdC) is now known to be a substrate for further oxidation. Oxidative
modifications to 5mdC, largely in the context of cytosine guanine dinucleotides (CpGs), are
catalyzed by enzymes of the ten-eleven translocation (TET) family, which are Fe(II) and αketoglutarate (α-KG) dependent dioxygenases. Step-wise oxidation of 5mdC by TET enzymes
can yield 5-hydroxymethyl-2’-deoxycytidine (5hmdC), 5-formyl-2’-deoxycytidine (5fdC), and 5carboxyl-2’-deoxycytidine (5cadC) (He, Y. F. et al., 2011; Ito, S. et al., 2011; Tahiliani et al.,
2009). These DNA modifications can function as potential intermediates in the long-sought
pathway for erasure of 5mdC, referred to as demethylation, and can also serve independent
functions regulating gene expression (Liu, M. Y., DeNizio, Schutsky et al., 2016). For example,
5hmdC is thought to activate loci silenced by methylation (Mellen et al., 2017), and intragenic
5hmdC in DNA may also impact RNA splicing (Marina et al., 2016). The distinctive localization
patterns of 5hmdC, 5fdC and 5cadC in sequencing studies further fuels speculation about
additional independent roles in epigenetic regulation (Wu, H. and Zhang, 2015).
Just as 2’-deoxycytidine (dC) modifications are widely prevalent in DNA, modifications to
the 5-position in cytidine (rC) in RNA are also found across all domains of life (Motorin et al.,
2010; Squires et al., 2012). 5-methylcytidine (5mrC) and its oxidized analogs (5hmrC, 5frC, and
5carC) are detectable in many types of RNA, including mRNA, tRNA, rRNA, and ncRNA (Huang,
W. et al., 2016; Motorin et al., 2010; Squires et al., 2012). Levels of 5mrC in total RNA vary
across tissues and organisms but can approach levels of 5mdC in DNA; for example, in mouse
brain, 5mrC comprises approximately 1% of total cytosines in RNA (Fu et al., 2014; Huber et al.,
2015), while 5mdC is 2-5% of cytosines in DNA (Globisch et al., 2010; Wagner et al., 2015). By
contrast, hydroxymethylation is approximately 2-3 orders of magnitude lower in RNA than in DNA
(Globisch et al., 2010; Wagner et al., 2015). Unlike for 5mdC in DNA, the function of 5mrC in
RNA is not well established, although potential roles in nuclear export of mRNA have been
demonstrated (Yang et al., 2017). In Drosophila, 5hmrC was found to be enriched in the coding
regions and may favor translation of mRNA transcripts, as more ribosomes were bound to mRNA
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containing 5hmrC (Delatte et al., 2016). With regards to demethylation, pathways for 5mrC
“removal” have not been found; however, the loss of 5hmrC has been shown to increase 5mrC
levels, suggesting the possibility of functional parallels (Shen, Q. et al., 2018).
Although DNA and RNA have unique methyltransferases involved in methylation
(Schapira, 2016), TET enzymes appear to be involved in oxidation of both DNA and RNA. In
mammalian systems, all three TET enzymes (TET1, UniProtKB Q8NFU7; TET2, UniProtKB
Q6N021; TET3, UniProtKB O43151) exhibited activity on 5mrC in vitro and in transfected cells
(Fu et al., 2014). TET1 and TET2 were also detected in an unbiased screen for RNA-binding
nuclear proteins in mouse embryonic stem cells (He, C. et al., 2016). Further support for TET
oxidation in both DNA and RNA comes from studies demonstrating that activity on both
substrates can be inhibited by the same means: Mutations in isocitrate dehydrogenase (IDH)
which result in accumulation of the competitive inhibitor 2-hydroxyglutarate, previously known to
impede DNA oxidation, have also been shown to reduce RNA oxidation (Xu, Q. et al., 2016).
Phylogenetic analysis also highlights a broader role for TET enzymes in acting on different
nucleic acids (Iyer et al., 2009; Iyer et al., 2013). Drosophila again provide a compelling example
in this regard; they lack the canonical 5mdC substrate in their DNA, but have a TET enzyme
homologue that appears to act on RNA as a bona fide substrate (Delatte et al., 2016; Raddatz et
al., 2013).
The observation of both DNA and RNA oxidation, as well as the diversity of potential
functions of 5mdC and 5mrC oxidation products, makes it a priority to understand how the nature
of the nucleic acid impacts TET activity. No systematic comparison of TET activity on various
configurations of DNA versus RNA has yet been performed, but previous biochemical
experiments and crystal structures provide a strong starting point for speculating about the
mechanistic features involved in DNA versus RNA oxidation (Hu, L. et al., 2013; Hu, L. et al.,
2015). In the structure of a truncated active human TET2 variant (TET2-CS) bound to a 12-mer
double-stranded (ds) DNA substrate, one of the most striking features is that 5mdC on the target
strand is flipped out of the duplex and into the active site of TET, raising questions about the
conformational flexibility required for dC- versus rC-based substrates. Outside of the target
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nucleotide, key contacts on the target DNA strand are largely confined to the phosphate
backbone, suggesting the possibility of promiscuity towards nucleic acid identity. Regarding the
impact and necessity of a complement strand, the structure and biochemistry present conflicting
data. Mutations of TET2-CS that could disrupt contacts with the complementary strand decrease
activity on dsDNA, but the effect on single-stranded (ss) DNA has not been tested in parallel(Hu,
L. et al., 2013). One study showed that dsDNA is more reactive than ssDNA (Fu et al., 2014),
while another suggested that ssDNA is more reactive (Kizaki, S. and Sugiyama, 2014). The
relative activities of TET enzymes on various DNA and RNA configurations are even less wellestablished. Early evidence suggested that the catalytic domain of mouse TET1 greatly prefers
dsDNA to a sequence-matched ssRNA substrate. TET-mediated oxidation to 5frC and 5carC has
also been demonstrated and could potentially occur in dsRNA, though oxidation to these forms
appeared to occur at very low efficiency (Basanta-Sanchez et al., 2017; Fu et al., 2014).
To better understand the breadth of TET enzyme capabilities, here we have performed a
comprehensive examination of the impact of nucleic acid identity on TET activity, by systematic
variation of the target base, target strand, and complementary strand of the substrates. Our
results show a dominant role for the target nucleotide in dictating the efficiency of oxidation.
Outside of this preference, TET2 has a surprising tolerance for most substrate configurations,
except for dsRNA, arguing that TET enzyme promiscuity makes these enzymes suited to diverse
biological roles. By placing our biochemical analysis in the context of targeted molecular
dynamics simulations, we further identify structural features that support this promiscuity as well
as potential mechanisms that can explain the observed spectrum of activity on DNA versus RNA
substrates.
2.3: Results
2.3.1: Design of Substrate Series
To probe TET’s capacity for reacting with various configurations of deoxyribo- versus
ribonucleic acids, we designed oligonucleotides that permitted systematic analysis of substrate
requirements for TET activity. Two different substrate series were generated for these
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experiments, each containing a 16-bp all-DNA oligonucleotide, as well as a matched all-RNA
oligonucleotide, which contain uridine in place of thymidine. These substrates contain a single 5methylcytosine (5mC) in a CpG sequence context: 5mdC in the all-DNA substrate (designated as
D(M)) or 5mrC in the all-RNA substrate (designated as r(m)) (Figure 2-1A). Given the potential
relevance of the sugar identity of the target base, which is extruded into the active site during
oxidation, we also designed chimeric substrates that could distinguish between the impact of the
identity of the target 5mC and that of other nucleotides on the target strand. In the DNA substrate,
5mdC was replaced with 5mrC (yielding D(m)), and vice versa for the RNA substrate (yielding
r(M)). Thus, Series 1 and 2 each contain four total oligonucleotides: D(M), r(m), D(m), and r(M).

Figure 2-1. TET2 discriminates mostly based on the sugar identity of the
target nucleotide rather than that of the flanking target strand.
A) Workflow showing the substrates and procedures used in the experiments. B)
Activity of TET2-CS with the Series 1 substrates. Reaction products were
quantified by LC-MS/MS and expressed as the percentage of each base relative
to the amount of total modified cytosine (DNA or RNA). C) The reaction in (B)
was repeated at three enzyme concentrations, and the reaction products were
expressed as total oxidation events: the generation of 5hmC counts once, 5fC
counts twice, and 5caC counts three times. D-E) The same experiments using
Series 2 substrates. Data for individual oxidation products used to generate (C
and E) can be found in Figure S2-2A,B. All error bars represent standard
deviation for 3-5 independent replicates.
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Notably, we designed Series 1 and 2 to be complementary to one another. For Series 2,
we generated two additional oligonucleotides that contained unmodified cytosine, rather than
5mC, in the all-DNA or all-RNA context (D(C) or r(c)). Comparing Series 1 substrates in the
absence or presence of either D(C) or r(C) complementary strands could therefore permit us to
examine single-stranded versus double-stranded nucleic acids. Furthermore, complexing Series
1 and 2 substrates that both contain reactive 5mC sites could permit an analysis of activity on
different strands in a duplex.
2.3.2: TET activity on 5mdC versus 5mrC
TET’s activity was first analyzed on the simplest iteration of the series, the all singlestranded substrates. In vitro reactions were performed using recombinant TET2-CS (Hu, L. et al.,
2013), and the reacted substrates were purified, digested to nucleosides and analyzed by LCMS/MS (Figure 2-1A, Figure S2-1). We first examined the product distribution at a 2:1 ratio of
substrate to enzyme. By displaying the data as the relative percentages of each modified
cytosine, the amount of remaining 5mC reflects the substrate consumption, while the flux through
the oxidative pathway is given by the relative distribution of the three forms of TET-oxidized
products. Under these conditions with Series 1, the DNA substrate (D(M)1) is entirely reacted,
while nearly all the RNA substrate (r(m)1) is converted (7% 5mrC remaining), indicating that the
RNA is a relatively proficient substrate. The DNA and RNA substrate reactions do differ, however,
in the extent to which they are oxidized: Roughly 80% of the DNA substrate is converted to the
higher oxidized modifications (5fdC and 5cadC), while the RNA substrate is primarily converted to
the first oxidative product, 5hmrC (65%) (Figure 2-1B). With the Series 2 substrates, the general
trends all hold, with the exception that TET less proficiently oxidizes r(m)2, with approximately
40% of the 5mrC substrate unreacted, relative to D(M)2 where 5mdC is completely consumed
(Figure 2-1D).
Given that driving conditions could obscure the comparison between relative reactivities
of the all-DNA and all-RNA substrates, we also examined reactivity at an 8:1 ratio of
substrate:enzyme. Under these conditions, there remains 2.6 and 5.2-fold as much RNA as DNA
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substrate for Series 1 and Series 2, respectively (Figure S2-2A,B). To see how far we could push
the oxidation of RNA, we also analyzed the reactivity at a 1:1 ratio of substrate to enzyme. For
both Series 1 and 2, while roughly 60% of 5mdC is oxidized to 5cadC, there is very little 5carC
generated from 5mrC (12% for Series 1 and none detectable for Series 2) despite near complete
consumption of 5mrC (Figure S2-2A,B). Interestingly, while only 12% of 5mrC remains unreacted
for r(m)2, it is almost exclusively converted to 5hmrC (81%), suggesting a greater barrier to
oxidation from 5hmC to 5fC for RNA than for DNA.
To facilitate a more rigorous comparison of the overall reactivity of substrates, we also
analyzed the data for total oxidation events for each substrate. Considering that 5fC and 5caC
both represent multiple catalytic events, total oxidation can be defined as the sum of the turnover
events, namely: (fraction of 5hmC) + 2×(fraction of 5fC) + 3×(fraction of 5caC) (Crawford et al.,
2016). Analyzing the data this way, the preference for ssDNA over ssRNA is evident and
maintained across different conditions. Specifically, we observed an average of 1.7 and 3.3-fold
more turnovers, for Series 1 and Series 2, respectively, with D(M) substrates relative to r(m)
substrates across the different concentration ratios (Figure 2-1C,E).
We focused our initial analysis on TET2-CS given that the variant is well-expressed and
more active than full catalytic domain variants of TET2 (TET2-CD). To test the generality of the
preference for ssDNA over ssRNA across the mammalian TET enzymes, we also examined the
reactivity of D(M)1 and r(m)1 with TET1-CD, TET2-CD and TET3-CD. Consistent with prior
studies, all three TET enzymes are capable of oxidizing both the ssDNA and ssRNA substrates,
and a consistent preference for oxidation of 5mdC in D(M)1 over 5mrC in r(m)1 was observed.
The proportion of reacted 5mdC, i.e. sum of the percentages of 5hmC, 5fC, and 5caC, in D(M)1 is
6.6-fold that of 5mrC in r(m)1 for TET1-CD, 1.5-fold for TET2-CD, and 5-fold for TET3-CD (Figure
S2-2C). Thus, activity can reliably be detected with both DNA and RNA, across two substrate
series, a range of substrate:enzyme ratios, and different TET variants, and ssDNA appears to be
consistently preferred over ssRNA for human TET enzymes.
To further explore the mechanistic basis for discrimination between ssDNA and ssRNA,
we next focused on the nature of the target nucleotide relative to the flanking residues of the
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substrates. After reacting TET2-CS with D(m)1, which differs from D(M)1 only by the addition of a
single 2’-hydroxyl at the target base, we quantified 5mrC and the 5hmrC, 5frC, and 5carC
oxidation products. With this substrate, the reactivity decreases significantly, with a turnover that
averaged 2.4-fold less across the substrate:enzyme ratios examined relative to D(M)1, and is
more comparable to the all-RNA substrate, r(m)1 (Figure 2-1C). The reciprocal change in the
r(M)1 substrate, which differs from r(m)1 only by the removal of a single 2’-hydroxyl at the target
base, shows a rescue of activity, with r(M)1 showing largely comparable activity to the all-DNA
substrate, D(M)1. Like the Series 1 substrates, the Series 2 substrates display a similar pattern,
where the distribution of oxidized products from r(M)2 more closely resembles that of D(M)2, while
that of D(m)2 is more similar to r(m)2 (Figure 2-1D). Thus, analysis of these chimeric substrate
oligonucleotides indicates that the difference in activity between ssDNA and ssRNA is largely
attributable to the target base identity, rather than the DNA or RNA character of the surrounding
bases.
2.3.3: Impact of complement strand on reactivity
We next sought to evaluate the impact of a complement strand and its nucleic acid
identity on TET activity. The Series 1 substrates, including the all-DNA strand, all-RNA strand,
and the two chimeric oligonucleotides, were each annealed to an unmethylated complement,
either the all-DNA strand, D(C)2, or the all-RNA strand, r(c)2. Given the wide range of substrate
reactivity observed across these permutations, the substrates were compared at a 1:1
substrate:enzyme ratio using TET2-CS. Under these conditions, the dsDNA (D(M)1:D(C)2)
substrate reacts to near completion, with almost complete conversion of 5mdC to 5cadC (Figure
S2-3A). Similarly, single-stranded D(M)1 shows complete consumption of 5mdC, and total
oxidation events are 92% of those observed with dsDNA (Figure 2-2A), as oxidation to 5cadC is
incomplete (Figure S2-3A). This small decrease in activity on ssDNA compared to dsDNA is also
be observed at a lower substrate:enzyme ratio where the total oxidation events of ssDNA are also
92% of dsDNA (Figure S2-3B), even though the oxidized products of both the ss- and dsDNA
substrates are predominantly 5hmdC and 5fdC (Figure S2-3B). Notably, with the full catalytic
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domains, TET2-CD shows a similar small reactivity preference for dsDNA over ssDNA, while
TET1-CD and TET3-CD are essentially agnostic to the presence or absence of the
complementary strand (Figure S2-4). As prior studies have hinted at a length dependence to
substrate reactivity (Hu, L. et al., 2015; Kizaki, S. and Sugiyama, 2014), we generated two
additional 5mdC-containing substrates containing the embedded D(M)1 16-mer sequence in a 27mer or a 60-mer oligonucleotide and compared ssDNA versus dsDNA reactivity. Although
reactivity of these substrates does decrease with length, the observation that dsDNA is more
reactive than ssDNA is maintained across all three substrates in the series (Figure 2-2B, Figure
S2-5). The observation that ssDNA reactivity is slightly enhanced by a DNA complement also
carries forward to the chimeric substrate D(m)1, though notably the target RNA base in D(m)1 has
the greater effect of lowering overall activity on both single and double stranded substrates
(Figure 2-2A).

Figure 2-2. Double-stranded DNA is the preferred TET substrate, while
dsRNA is strongly disfavored.
A) Activity of TET2-CS on Series 1 substrates, either single-stranded or duplexed
to a non-reactive DNA or RNA complementary strand. B) Comparison of TET2CS activity on sequence-matched ssDNA versus dsDNA substrates of different
lengths. Error bars represent standard deviation for 2-3 independent replicates.
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In contrast to the improved reactivity when duplexing DNA with DNA, duplexing any
target strand with RNA dampens reactivity. TET2-CS showed reactivity on the 5mdC of the
DNA:RNA hybrid duplex (D(M)1:r(c)2), but total oxidation events are decreased relative to the
dsDNA substrate D(M)1:D(C)1 (23% reduction); in comparison, D(m)1 experiences an even
greater reduction in reactivity (68%) when complexed to RNA (Figure 2-2A). Interestingly, for the
chimeric r(M)1 substrate, whose reactivity rivaled the all-DNA D(M)1 substrate when singlestranded, reactivity decreases when duplexing this substrate to the DNA complement and
decreases further when duplexing to the RNA complement. The disfavored nature of an RNA
complementary strand is most evident with the all-RNA substrate, r(m)1, where reactivity is nearly
eliminated on the dsRNA substrate, contrary to prior suggestions that dsRNA may be a substrate
(Basanta-Sanchez et al., 2017). Thus, although the target base identity is a critical determinant of
reactivity with single-stranded substrates, these preferences can be overridden by disfavored
duplex structures in the rest of the substrate.
2.3.4: Activity on symmetrically methylated duplexes
Our analysis of duplex substrates initially focused on a single reactive 5mC site in the
target strand, but we recognized that these substrates are well suited to examining a more
complex question. Considering that most CG:CG dinucleotide pairs in genomic DNA are
symmetrically methylated (Schubeler, 2015), TET enzymes likely encounter duplex substrates
where both strands contain reactive 5mC nucleobases. The DNA:RNA hybrids, D(M)1:r(m)2 and
D(M)2:r(m)1, as well as the chimera hybrids, D(m)1:r(M)2 and D(m) 2:r(M)1, are instructive
experimental substrates, as in each case, activity on each strand can be assessed independently,
given that one strand contains 5mdC, while the other contains 5mrC. With D(M)1:r(m)2 and
r(m)1:D(M)2, we observed nearly symmetrically-reciprocal results, with high activity on the all-DNA
strand and less activity on the all-RNA strand in both cases (Figure 2-3A). Notably, comparing
these two DNA:RNA hybrids with the dsDNA duplex (5mC on both strands) shows a greater
proportion of the 5mdC converted to 5cadC for the all-DNA substrate (Figure 2-3B). This result
suggests that having an RNA complement strand, whether it is reactive or non-reactive as above,
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decreases activity on the DNA strand. With the chimeric substrates, D(m)1:R(M)2 and r(M)1:D(m)2,
the RNA strand containing 5mdC is more reactive than the DNA strand containing 5mrC (Figure
2-3). This observation is consistent with a dominant influence for the identity of the target
nucleotide over that of the flanking nucleic acids in the target strand.

Figure 2-3. For duplexes with two reactive strands, TET2 activity on each
strand is largely independent of the other, complementary strand.
A) Series 1 and 2 substrates, each containing 5mC, were duplexed to one
another. Reaction products are shown as the total oxidation events on each
strand. B) Reaction products from the same reactions are also shown as
percentages of each modification for DNA (top half of graph) or RNA (bottom half
of graph) targets. Also included for comparison are results for symmetrically
methylated dsDNA and dsRNA, showing the reaction products for both strands
combined. Error bars represent the standard deviation for 3 independent
replicates.
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2.3.5: Modeling of 5mrC in TET-dsDNA structure.
We have used classical molecular dynamics (MD) simulations to examine the TET2-CS
structure complexed to dsDNA (Liu, M. Y. et al., 2017) in order to understand the mechanisms
that could contribute to nucleic acid selectivity. Given the importance of the target site identity
revealed by our biochemical analysis, we converted 5mdC to 5mrC by inserting a single 2’hydroxyl at the target 5mdC base and then examined its impact on non-bonded interactions and
H-bond dynamics. The MD results provide a qualitative assessment that help explain the
tolerance of TET2 toward 5mrC at the target site, as well as the preference for oxidation of 5mdC
over 5mrC.
The mutation of 5mdC to 5mrC results in both global and local changes in the structure
and dynamics of the system that help explain the decreased reactivity of 5mrC (Figure 2-4, S2-68). At a global level, the inclusion of the 2’-OH results in an overall destabilizing interaction of the
DNA with the protein (ΔE5mdC system - 5mrC system=-47.4 kcal/mol) (Figure 2-4A). Additionally, the
normal mode analysis of both systems suggests that the dynamics are also affected by the
inclusion of the 2’-OH (Figure S2-6A,B). Interestingly, the substitution of 5mdC with 5mrC in the
target strand creates a partial shift from B-form DNA, most distinctly shown by the change in shift
and slide toward A-form character in two base pairs upstream (5’) of the target base (Figure S27), as well as altered intermolecular interactions spanning the R1260-R1269 region of the
enzyme (Figure S2-8). The A-form is common in RNA and DNA-RNA duplexes and in proteinDNA complexes for polymerases and endonucleases (Kulkarni and Mukherjee, 2017). These
alterations could partially explain the decreased reactivity of the 5mrC chimeric substrates as well
as the more profound defect in oxidation of dsRNA that was observed.
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Figure 2-4. Modeling 5mrC as the target base in dsDNA bound to hTET2
results in dynamic and structural changes.
A) The active site of TET2-CS (green) bound to dsDNA (teal) containing 5mrC.
B) H-bond network and energetic differences in models of the active site with
either 5mdC (top) or 5mrC (bottom). H-bonds (present >10% simulation time in at
least one system) are designated by dashed lines, including those that occur in
both models (<10% difference, black). When there is more than one bond that
contributes to an interaction between two molecules, it is shown as a dotted line
and the simulation time present is not shown (see Figure S2-8 for all contributing
data). For H-bonds that occur in both systems but at different levels (>10%
difference), the bond line is thinner in the system in which it is less prevalent.
Significantly different non-bonded interactions (sum of Coulombic and van der
Waals energies >|1| kcal/mol) between a TET residue and the target 5mC in the
two systems are highlighted according to the relative magnitude of the difference
(see Table S2-1 for values).
A more local view of the active site sheds light on differences that can explain the
decreased reactivity of 5mrC, but also the preservation of core elements that permit 5mrC to be
oxidized. The 2’-OH of 5mrC does not introduce any evident steric conflicts but results in the
formation of an H-bond with the phosphate backbone of G7, the downstream base in the CpG
dyad (Figure 2-4, Figure S2-8, Table S2-1). This DNA structural change alters the interactions of
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the substrate in the active site, including an increase in the predominance of the H-bonds
between G7 and S1290 and K1299 with the simultaneous loss of H-bonds from T1259 and
S1286 to G7. Residues R1261 and R1262, which form key interactions with the target base
backbone (Figure S2-8) and with the αKG analog, respectively, are stabilized via additional
Coulomb and van der Waals interactions in the 5mrC system. Nonetheless, despite these
interactions with the backbone of the target strand, there are changes suggesting decreased
engagement of the nucleobase to the enzyme: In addition to loss of an H-bond between S1290
and the nucleobase, the H-bond interactions on the Watson-Crick face of the nucleobase from
H1904 are reduced by a third of the overall simulation time in the 5mrC-containing structure
compared with the 5mdC system. Notably, other core components of the active site are largely
intact. In particular, we have previously demonstrated the importance of an active site scaffold in
modeling and mutagenesis experiments, whereby the active site T1372 hydrogen bonds with
Y1902, which stacks with the target cytosine nucleobase to position it optimally for oxidation (Liu,
M. Y. et al., 2017). The introduction of 5mrC does not have a noticeable impact on the
intermolecular interactions of the scaffold.
2.4: Discussion
Given the expanded recognition of the role of oxidized 5mC bases in DNA and RNA
biology, here we employed a systematic approach to explore the nucleic acid determinants of
TET reactivity. Our results offer a view of the selectivity and promiscuity that characterizes TETmediated oxidation and allow for substantiation of a model (Figure 2-5) that links reactivity to the
nature of the target nucleotide, the flanking nucleotides on the target strand, and the
complementary strand.
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Figure 2-5. Summary of substrate determinants of TET reactivity from
biochemical findings.
The 2’-OH present in 5mrC, but absent in 5mdC, is shown in parentheses. The
complement strand is shown as a dashed line to indicate that it is not required for
TET activity.
Our results uncover a strong association between the nucleic acid identity of the target
nucleotide and TET reactivity. We find that TET enzymes are tolerant to both ssDNA and ssRNA
substrates, but ssDNA substrates are preferred, consistent with past studies (Fu et al., 2014).
Strikingly, the diminished reactivity of the ssRNA can be rescued by removing the single 2’-OH
from the target nucleotide. Correspondingly, the addition of a single 2’-OH at the target nucleotide
decreases the reactivity of ssDNA to the level observed with the ssRNA substrate. These results
align with findings from an in vitro study showing that TET can oxidize substrates containing 2’(R)-fluorinated modified cytosines, albeit to a lesser extent than 5mdC-containing DNA (Schroder
et al., 2016). In support of our biochemical findings, molecular dynamic simulations suggest that
the addition of a single 5mrC in the active site of a TET2-dsDNA structure can be accommodated,
allowing for key nucleobase-orienting interactions to be maintained, but results in significant
energetic and conformational changes surrounding the target base relative to 5mdC which could
explain its altered reactivity. These findings are interesting to consider in the context of other
DNA/RNA modifying enzymes. Some enzymes, such as the base excision repair enzyme uracil
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DNA glycosylase, potently discriminate against a ribonucleotide target using steric discrimination
against the 2’-OH (Pearl, 2000). For other enzymes, such as AID/APOBEC family DNA
deaminase enzymes, a preference for a deoxynucleotide over ribonucleotide target appears
linked to the preferred sugar puckers accessible to the DNA substrates (Nabel et al., 2013). The
modeling with TET2-CS suggests an alternative mechanism that can explain tolerance for 5mrC,
but a preference for 5mdC. The 5mrC substrate can be accommodated from a steric and
conformational perspective, but the interactions of the reactive base appear disfavored relative to
5mdC.
Our biochemical data also inform our understanding of the role of the flanking and
complementary strand nucleotides on activity. dsDNA is the preferred substrate, but DNA:RNA
hybrids are also tolerated when the DNA is the substrate (Figure 2-5). The only conformation that
appears to be strongly discriminated against is dsRNA. While a single 5mdC can alleviate some
of the negative effects of the RNA duplex, it is still strongly disfavored, possibly due to the
discrimination against A-form conformations. The proficiency for oxidation of ssRNA suggests
that the conformational flexibility available to single-stranded substrates, but not dsRNA,
facilitates promiscuous oxidation of 5mC. In considering the impact of the nucleotides outside of
the target site, TET2 offers an interesting comparison to another nucleotide-flipping enzyme, the
RNA methyltransferase, DNMT2. When methylation activity was examined on tRNA substrates, a
chimera that contains a dC in place of rC in the loop region of the tRNA substrate was more,
rather than less, efficiently methylated than the all-RNA natural analog (Kaiser et al., 2017).
Therefore, rather than having selectivity primarily dictated by the target nucleotide as we observe
for TET2, the flanking nucleotides and their secondary structure determines reactivity for DNMT2.
The evident promiscuity in TET family enzymes raises important points with regards to
their physiological function. dsDNA, ssDNA, ssRNA, and DNA:RNA hybrids co-exist in
mammalian cells and represent four of the five most preferred substrates across our tested
series, which lends biochemical credence to the possibility that TET oxidation products could be
generated in any of these settings. At the same time, the observed promiscuity in vitro raises
questions about how TET-mediated oxidation could be targeted in vivo. For functions when
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activity on DNA predominates, spatial regulation is likely to play an important role. TET1 and
TET2 have been shown to primarily localize to the nucleus in both overexpression studies and in
cells, while TET3 localizes to both the cytoplasm and the nucleus (Arioka et al., 2012; Di Stefano
et al., 2014; Huang, Y. et al., 2016; Muller et al., 2012). Regulation could also involve the noncatalytic domains and/or partner proteins. Our studies focused on the crystal structure version of
TET2 and the catalytic domains of TET1-3, but full-length TET1 and TET3 have CXXC-domains
that can mediate targeting to non-methylated CpG islands in DNA, while TET2 is thought to utilize
its ancestral gene neighbor, IDAX, for this purpose (Ko et al., 2013). For functions where activity
on RNA is thought to predominate, major questions remain open regarding the location and
timing of cytosine methylation in RNA and how selectivity for TET-mediated oxidation could be
achieved.
More broadly, beyond the mammalian TET1-3 enzymes, it will be interesting to see if
promiscuity towards DNA and ssRNA is a shared feature of the TET enzymes found across the
phylogenetic tree, especially in organisms that offer a restricted or unusual selection of nucleic
acid substrates (Iyer et al., 2009; Iyer et al., 2013). TET homologs in some species have been
associated with transposons and retroelements, suggesting the possibility that their activity could
be associated with less conventional nucleic acid intermediates associated with mobile genetic
elements (Iyer et al., 2014). Among the species with distinct TET homologs, Drosophila stand out
in particular since they lack methylated DNA yet have retained a TET homolog that appears to act
on RNA. Whether the proposed impact on protein translation applies to other species, or whether
this represents a unique branch point in the evolution of TET activity, remains to be explored. Our
findings are also interesting to consider in the context of the broader nucleic acid dioxygenase
family, which also includes AlkB family enzymes. The promiscuity of AlkB enzymes towards DNA
and RNA has been thought broaden their function in nucleic acid repair (Falnes et al., 2004) and
may have been exploited in the evolution of diverse physiological functions potentially associated
with TET enzymes.
The observed promiscuity of TET activity adds to the challenges of studying DNA and
RNA cytosine modifications. In knockouts, phenotypes attributed to activity on 5mdC in DNA, may
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instead be related to altered oxidation of 5mrC in RNA or vice versa. Engineering of TET2-CS
has been able to yield variants with altered selectivity (Liu, M. Y. et al., 2017; Sudhamalla et al.,
2018). Our MD simulations suggest that it may similarly be possible to find mutants with altered
selectivity by manipulating the interactions that differentiate 5mdC from 5mrC engagement in the
active site. For example, mutations of key residues such as S1290 or K1299 in TET2 could
potentially enhance or diminish the activity on DNA versus RNA. Indeed, beyond improving our
understanding of the molecular determinants of enzyme selectivity, building enhanced specificity
into TET enzymes could offer tools to better explore their biological roles as well as expand the
power of CRISPR/dCas9-based epigenetic editing biotechnology (DeNizio et al., 2018; Komor et
al., 2017).
2.5: Methods
2.5.1: Oligonucleotide preparation
DNA oligonucleotides were purchased from Integrated DNA Technologies (IDT). RNA
oligonucleotides and DNA/RNA chimeras were purchased from Trilink. All oligonucleotides were
HPLC purified and the masses confirmed. The oligonucleotides were resuspended in 10 mM TrisCl pH 7.5 and quantified by UV absorbance spectroscopy, using the extinction coefficient at 260
nm for each oligonucleotide. All substrates were diluted to 10 μM (of reactive, methylated
substrate, whether single- or double-stranded) in 10 mM Tris-HCl pH 7.5 and 50 mM NaCl.
Duplexed oligos were annealed by heating to 95 °C for 30 s and cooling at 1 °C increments, for
15 s per step, to 4 °C.
2.5.2: Purification of TET enzymes from Sf9 insect cells
The crystalized human TET2 variant (TET2-CS) includes residues 1129–1936 Δ1481–
1843 (Hu, L. et al., 2013). The full catalytic domains of TET2 (TET2-CD, residues 1129–2002),
TET1 (TET1-CD, 1418–2136), and TET3 (TET3-CD, 689–1660) were also purified. These
constructs, with an N-terminal FLAG tag, were subcloned into a pFastBac1 vector for Sf9 insect
cell expression, as described previously (Liu, M. Y., DeNizio, and Kohli, 2016). Expression was
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carried out for 24 hr. Cells from a 1 L culture were collected and resuspended in lysis buffer (50
mM HEPES, pH 7.5, 300 mM NaCl, 0.2% (v/v) NP-40) containing cOmplete, EDTA-free Protease
Inhibitor Cocktail (Roche, 1 tablet/10 mL). Cells were lysed by three passes through a
microfluidizer at 15,000 psi. The lysate was cleared by centrifugation at 20,000g for 30 min. The
supernatant was then passed two to three times over a 500 μL or 1 mL packed column of antiFLAG M2 affinity resin (Sigma), prepared according to the manufacturer’s instructions. The
column was washed three times with 10 mL of wash buffer (50 mM HEPES, pH 7.5, 150 mM
NaCl, 15% (v/v) glycerol). To elute the bound protein, one column volume of elution buffer (wash
buffer containing 100 μg/mL of 3× FLAG peptide (Sigma)) was incubated on the column for 10
min, and serial elutions were collected until no more protein was detected by Bio-Rad Protein
Assay and SDS-PAGE. The three most concentrated fractions were pooled, aliquoted, and stored
at −80 °C. Protein concentrations were measured using a Qubit 4 Fluorometer (Invitrogen) prior
to use in in vitro activity assays.
2.5.3: TET reactions on DNA and RNA substrates
Substrates were diluted to the designated concentrations in reaction buffer (50 mM
HEPES, pH 6.5, 100 mM NaCl, 1 mM α-KG, 1 mM DTT, and 2 mM sodium ascorbate). Fresh
ammonium iron(II) sulfate (Sigma) was added to 75 μM prior to initiation, and purified enzyme
was added last to start the reaction (t = 0), bringing the total volume to 25 μL. This mixture was
incubated at 37 °C for 30 min. Reactions were quenched by addition of pre-mixed quenching
solution (25 μL H2O, 100 μL Oligo Binding Buffer (Zymo), and 400 µL ethanol). Oligonucleotide
products were purified using the Zymo Oligo Clean & Concentrator kit, eluted in 10 μL of Millipore
water, and analyzed by LC-MS/MS.
2.5.4: Quantification of reaction products by LC-MS/MS
The purified TET reaction products were degraded to component DNA and/or RNA
nucleosides using 1 µL of Nucleoside Digestion Mix (New England Biolabs) in 10 µL total volume
for 4 hours at 37 °C. The mixture was diluted 10-fold into 0.1% formic acid, and approximately 2
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pmol was loaded onto an Agilent 1200 Series HPLC equipped with a 5 μm, 2.1 × 250 mm
Supelcosil LC-18-S analytical column (Sigma) equilibrated to 45 °C in Buffer A (0.1% formic acid).
The nucleosides were separated in a gradient of 0–10% Buffer B (0.1% formic acid, 30% (v/v)
acetonitrile) over 8 min at a flow rate of 0.5 mL/min. Tandem MS/MS was performed by positive
ion mode ESI on an Agilent 6460 triple-quadrupole mass spectrometer, with gas temperature of
225 °C, gas flow of 12 L/min, nebulizer at 35 psi, sheath gas temperature of 300 °C, sheath gas
flow of 11 L/min, capillary voltage of 3,500 V, fragmentor voltage of 70 V, and delta EMV of
+1,000 V. Collision energies were 10 V for all bases, aside from C and 5hmC for which the
collision energies were 25V. MRM mass transitions were {dC 228.1112.1 m/z; dT
243.1127.1; 5mdC 242.1126.1; 5hmdC 258.1124.1; 5fdC 256.1140.0; 5cadC
272.1156.0; rC 244.1112.1; 5mrC 258.1126.1; 5hmrC 274.1124.1; 5frC 272.1140.0;
5carC 288.1156.0}. Standard curves were generated from standard deoxyribonucleosides
(Berry & Associates) and ribonucleotide triphosphates (Trilink), first digested to nucleosides using
the Nucleoside Digestion mix under the same conditions as above prior to serial dilution, from
1,250 fmol to 0.614 fmol (Figure S2-1); sample peak areas were fit to the standard curve to
determine amounts of each modified cytosine in the sample. Results are expressed as the
percentage of each modified cytosine out of all modified DNA or RNA bases detected.
Alternatively, to quantify total oxidation events, we considered that TET enzymes catalyze one
oxidation reaction to generate 5hmC, two reactions to generate 5fC, and three reactions to
generate 5caC. Therefore, we expressed total oxidation events as 1×(% 5hmC) + 2×(% 5fC) +
3×(% 5caC) (Crawford et al., 2016).
2.5.5: Molecular dynamics simulations
Molecular dynamics (MD) simulations were performed using the ff99SB force field with
the pmemd.cuda program from the AMBER16 software suite(Case et al., 2017; Salomon-Ferrer
et al., 2013). The 5mrC system was created from a crystal structure of the human TET2-DNA
complex (PDBID: 4NM6) (Hu, L. et al., 2013). Similar to our previous simulations (Liu, M. Y. et al.,
2017), the current system includes magnesium as a surrogate for iron in the active site,
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coordinated His residues protonated on ND1, and a linker inserted using Modeller (Fiser et al.,
2000; Sali and Blundell, 1993).
The previously published deoxyribonucleotide parameters for cytosine derivatives, αketoglutarate, Mg(II), and Zn were used (Liu, M. Y. et al., 2017), and ribonucleotide parameters
for 5mrC were generated using PyRED (Bayly et al., 1993; Dupradeau et al., 2010; Vanquelef et
al., 2011; Wang, F. et al., 2013). The system with 5mrC was generated using the LEaP module
(Frisch et al., 2016) and neutralized to a net charge of zero with potassium ions and then solvated
in a truncated octahedron of TIP3P water extending at least 12 Å from the complex surface
(Jorgensen et al., 1983). SHAKE was used for all bonds involving hydrogen, and long-range
Coulomb interactions were treated using the smooth particle mesh Ewald method with a 9 Å
cutoff (Essmann et al., 1995). Simulations were carried out with the Berendsen thermostat in the
NVT ensemble with a 2 fs time-step for 100 ns (Berendsen et al., 1984).
All dsDNA 5mdC reference calculations were performed with Langevin dynamics. Two
tests were performed in order to validate that meaningful comparisons could be made between
the 5mrC system and the previous work with the 5mdC system. These tests included a single 100
ns run of the 5mrC system with Langevin dynamics (minimization in the NVT ensemble and
production in the NPT ensemble with the Berendsen barostat; collisional frequency of 1.0 ps-1)
and a 1 fs time-step, and a single 100 ns run of the 5mdC system with the Berendsen thermostat
in the NVT ensemble and a 2 fs time-step used for the dynamics reported here.
Upon confirming compatibility, each simulation was carried out three times and data were
averaged across replicates. The cpptraj program in AMBER was used to analyze trajectories for
correlations, hydrogen bonding, atomic fluctuations, root mean square deviations, residue
distances, and nucleotide angular parameters (Babcock et al., 1994; Olson et al., 2001; Roe and
Cheatham, 2013). Energy decomposition analysis (EDA) was performed using an in-house
FORTRAN90 program to investigate the Coulomb and van der Waals interactions between
individual residues throughout the simulation (Dewage and Cisneros, 2015; Elias and Cisneros,
2014; Graham et al., 2012). VMD and the ProDy interface were used in principal component
(PCA) and normal mode (NMA) analyses (Bakan et al., 2011; Humphrey et al., 1996). The first
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100 PCA modes were calculated from each trajectory using 5,000 snapshots. UCSF Chimera
was used to generate images (Pettersen et al., 2004).
2.6: Supplementary Information
2.6.1: Supplementary Figures

Figure S2-1. Representative nucleoside standard curves for LC-MS/MS
analysis.
There is little to no discrepancy between the detection levels of dC (A) and rC (B)
nucleosides. (C) Raw data used to generate the standard curves and the
resulting slope of the line, which is used to normalize the raw sample data.
Standards were collected on each day of MS collection and used to normalize
the temporally appropriate data.
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Figure S2-2. All human TET isozymes can oxidize ssDNA and ssRNA.
(A-B) Activity of TET2-CS on ssDNA and ssRNA substrates from Series 1 and 2.
The data shown here for 1 μM TET2-CS is the same as in Figure 2-1B,D, and the
data are alternatively expressed as total oxidation events in Figure 2-1C,E. (C)
Activity of the full catalytic domains of TET1-3 on ssDNA and ssRNA substrates
from Series 1. Error bars represent standard deviation for 3 replicates.
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Figure S2-3. Double-stranded DNA is preferred, while dsRNA is strongly
disfavored for two different reaction conditions.
(A) Activity of 2 μM TET2-CS on ss- and ds-substrates. These reaction products
are alternatively expressed as total oxidation events in Figure 2-2A. Error bars
represent standard deviation for 2-3 replicates. (B) Total oxidation events (top)
and relative reaction products (bottom) of reactions with 500 nM TET2-CS and
the same series of ss- and ds-substrates.
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Figure S2-4. TET2-CD shows slight preference for ds- over ssDNA, while
TET1- and TET3-CD are equally reactive on these substrates.
Error bars represent standard deviation for 3 replicates. The ssDNA data are
replicated from Figure S2C for clarity.

Figure S2-5. Preference for ds- over ss-DNA is consistent at various DNA
lengths.
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(A) Design of sequence-matched DNA substrate length series. (B) Activity of
TET2-CS on the length series (total oxidation events shown in Figure 2-2B).
Error bars represent standard deviation for 2-3 replicates.

Figure S2-6. Global changes in dynamics and energetics of TET2 bound to
dsDNA with 5mrC.
(A-B) Normal mode analyses, showing mode 1 (purple), mode 2 (green), mode 3
(blue) of 5mdC- (A) and 5mrC-containing systems (B). (C) Structure of TET2
colored by changes in total interaction energy (sum of Coulomb and van der
Waals energies) of each residue or base relative to the target 5mC between the
models containing 5mdC and that containing 5mrC in dsDNA. TET residues
showing significant changes in H-bonding and non-bonded interactions, as well
as surrounding DNA bases, are shown as sticks. (D) Average total interaction
energies >|1 kcal mol-1|, used to calculate the differences displayed in Panel C,
shown side-by-side here for each residue.
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Figure S2-7. 5mrC-containing system displays shift from B-form to A-form
DNA.
(A) Shift and slide for C3•G3’ and A4•T4’ in dsDNA with either 5mdC or 5mrC.
Parameters from all replicates are shown. (B) Delta and chi angles for the target
5mC in dsDNA. Angles from all replicates are shown.
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Figure S2-8. Expanded view of H-bond network and energetic differences in
the active site of TET2 with dsDNA containing either 5mdC or 5mrC.
Expanded data from Figure 2-4 of TET2 in complex with dsDNA containing either
5mdC (left) or 5mrC (right). H-bonds (>10% simulation time in at least one
system) are designated by dashed lines, including those that occur in both
systems (<10% difference, black). When a H-bond occurs unequally (>10%
difference) in both systems, it is shown as a thinner dashed line in the system in
which it is less prevalent. Significantly different non-bonded interactions (sum of
Coulomb and van der Waals energies >|1 kcal mol-1|) between a TET residue
and the target 5mC in the two systems are highlighted according to the relative
magnitude of the difference (see Table S2-1 for values).
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2.6.2: Supplementary Tables

Table S2-1. Differences in the total non-bonded interactions between the
5mC-containing nucleotide and the specified base or residue (in kcal mol-1;
ΔE ± avg. st. dev.).
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CHAPTER 3: Biochemical basis for depletion of CpH hydroxymethylation in genomes rich
in CpH methylation
3.1: Introduction
Both the hereditary propagation and dynamic nature of cytosine modifications are critical
for transcriptional regulation in mammals, influencing cell development and maintenance. The
most common epigenetic mark, 5-methylcytosine (mC), primarily occurs at cytosine-guanine
dinucleotides (CpGs), with 60-80% of CpGs methylated in most cell types. In differentiated cells,
CpHs (H=A,C,T) are rarely methylated, but in embryonic stem cells (ESCs) and brain cells, as
much as 2-6% of CpHs can be methylated (Jang et al., 2017). In these cell types, due to the
relative scarcity of CpG dinucleotides across the genome as a whole, mCpHs can account for up
to half of all methylated cytosines in the genome despite the lower fraction of modification sites
(Kinde et al., 2015).
Importantly, mC is not the only relevant mark that occurs on cytosine bases in
mammalian genomes. In all cell types, 5-hydroxymethylcytosine (hmC) has also been identified
as a stable modification; it is prevalent in ESCs and can account for up to 1% of all nucleotides in
neurons. The Ten-eleven translocation (TET) family of enzymes, which are Fe(II)/αketoglutarate(αKG)-dependent dioxygenases, are responsible for introducing this mark by
oxidizing mC; the hmC product can then be further oxidized to yield 5-formylcytosine (fC), or yet
again to 5-carboxycytosine (caC). While independent roles for each of the oxidized mC bases
(oxmCs) remain subject to ongoing studies, oxmCs have been implicated in pathways for DNA
demethylation. That is, the presence of an oxmC at one cytosine in CpG•CpG base pairs can
prohibit the maintenance methylation of the other cytosine, promoting passive demethylation. The
higher oxidation states, fC and caC, can also be actively excised by the base excision repair
enzyme, thymine DNA glycosylase (TDG); repair of the excised base leads to the installation of
unmodified cytosine in place of the modified base, yielding a complete biochemical pathway for
active demethylation of mC.
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Although mCpHs are robustly detected in ES and neuronal cells, the presence of
oxmCpHs is more controversial. Different sequencing methodologies have offered differing
results regarding the presence of hmCpHs in vivo. With Pvu-Seal-seq, which utilizes an hmCspecific restriction enzyme to localize hmC at single-base resolution, 24% of hmCs detected were
in CpH contexts in ESCs (Sun et al., 2015). In contrast, TET-assisted bisulfite-sequencing (TABseq) (Yu et al., 2012) and APOBEC-coupled epigenetic sequencing (ACE-seq) (Schutsky et al.,
2018), both of which can specifically localize hmC at base resolution, detected very few hmCpHs
in both ESCs and neurons.
Regardless of these discrepant results, in each instance there is not a proportional
amount of hmCpH relative to mCpH, compared to the ratio of hmCpG to mCpG. There are two,
non-mutually exclusive explanations to account for these observations: The first, that TET
enzymes may be resistant to oxidation of mCpH (Masser et al., 2018). The second, that hmCpH
may be particularly susceptible to active demethylation via the TET/TDG pathway, restoring
unmodified CpH. In this chapter, I will examine the intrinsic substrate preferences of both TET
and TDG to test these hypotheses.
Structural and biochemical studies of TET enzymes also provide conflicting evidence with
regards to the tolerance for oxidation at sites with non-G bases 3’ downstream of the target site,
or at the +1 position. Using the human TET2 variant that allowed for crystallization with duplex
DNA (TET2-CS), Hu et al. compared TET oxidation on mCpG versus mCpA and mCpC (Hu, L. et
al., 2013). While the mCpG is almost fully oxidized, very little of both the mCpA and mCpC are
converted. The associated crystal structure with mCpG-containing DNA led the authors to
propose that a non-G base at the +1 position would impede the base-stacking interaction
between it and the TET active site residue Y1294, resulting in diminished activity.
Despite this claim, there is in vitro evidence that a TET homolog can efficiently oxidize a
target modified base when in a CpH sequence context. Specifically, although a TET homolog
from N. gruberi, NgTET1, generally prefers CpG for all three substrates (mC/hmC/fC), it can
oxidize DNA containing mCpG and mCpA with comparable efficiency (Pais et al., 2015). Further,
there is only about a 3-fold decrease in activity on DNA containing mCpT and mCpC. With hmC51

containing DNA, there is only about a 2-fold decrease in TET reactivity compared to hmCpG for
all three CpH sequence contexts. Thus, it will be informative to observe the activity of human
TET2 on the full range of possible modified cytosine substrates in each of the four dinucleotide
sequence contexts.
TDG has also been shown to be active in a variety of non-CpG contexts, including on
bases other than a mismatched T. Although TDG activity on a G•T mismatch is the most
impacted by the identity of the +1 base, all of the other substrates tested also show some level of
discrimination (Morgan et al., 2007). The crystal structure of a truncated form of TDG (residues
82-308) in complex with double-stranded DNA containing a G•U mismatch reveals several TDG
interactions with the 3’-G base (Coey et al., 2016). It was proposed that these interactions likely
stabilize the TDG insertion loop within the DNA helix, aiding nucleotide flipping into the active site.
To support this theory, a recent study showed that the nucleotide flipping of T in a G•T mismatch
is sequence-dependent, particularly with regards to the +1 base; that is, the flipped state occurs
less frequently for T in CpH contexts, likely to prevent abberant removal of T from normal A•T
pairs (Dow et al., 2019). Although nucleotide flipping of fC and caC have not been measured, the
TDG interactions with the 3’-G are maintained in a structure with fCpG (Pidugu et al., 2016), as
well as in one with caCpG (Zhang, L. et al., 2012), suggesting that TDG may exhibit +1 base
discrimination as well.
Here, we test whether the intrinsic substrate preferences of TET and TDG enzymes can
possibly explain the depletion of hmCpH observed in relevant genomes. Steady-state
measurements of TET oxidation products revealed that TET2 is impacted by the identity of the +1
base when oxidizing mC but, surprisingly, not hmC. Also, we observed that TDG can excise fC
and caC efficiently regardless of sequence context. Thus, our evidence supports a biochemical
pathway that favors the oxidation and eventual excision of hmCpH, despite the relative
preference for mCpGs.
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3.2: Results
3.2.1: Impact of +1 base on TET oxidation
To investigate the impact of the +1 base on TET reactivity, we chose to use the crystal
structure variant of human TET2 (TET2-CS). TET2-CS is a more stable construct, allowing for
profiling of a larger range of activity. Importantly, substrate preferences with this construct have
been previously shown to be consistent with that of the TET2 construct with a full catalytic domain
(DeNizio et al., 2019; Liu, M. Y. et al., 2017). To assess the relative substrate preferences of
TET2 here, we devised a matched substrate series with twelve different oligomers, each having
one of the three substrate, modified cytosine bases (mC, hmC, and fC) in each of the four
possible sequence contexts (CpG, CpC, CpA, and CpT) (Figure 3-1A). Reactions were performed
in conditions that have been previously optimized for overall activity (Crawford et al., 2016; Liu,
M. Y. et al., 2017).

Figure 3-1. TET oxidation of XpY dinucleotides.
A) Substrates were designed to contain a single target modified cytosine (X) in a
dinucleotide pair with one of the four bases (Y), base paired to its unmodified,
respective partner (Z). B) Activity of TET2 with each of the twelve substrates.
Reaction products were quantified by LC-MS/MS and expressed as the
percentage of each base relative to the amount of total modified cytosine. The
reaction products of each sample in B) are expressed as total oxidation events
(TOE) using the respective equations in C). D) TOE are normalized to the
respective maxima of oxidation events and then presented relative to the mCG
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(left y-axis). The ratios of these values for hmC/mC are also shown as blue stars
for each respective sequence context (right y-axis).
TET2 activity on the mC-containing substrates, under conditions with both excess and
limiting enzyme, showed that mCpG is the most reactive substrate, as predicted. The mCpH
substrates are less oxidized (Figure 3-1, 3-2); only 9% of mCpG remains unreacted, while the
most converted of the three mCpHs, mCpA, has 55% substrate remaining (Figure 3-1B). Notably,
however, all three mCpH substrates generate caC, with the mCpH substrates oxidizing to as
much as half the proportion of caC that mCpG does, despite there being about a 6-fold difference
in substrate consumed. Given the challenges posed by assessing the linked products, we also
examined product formation by considering the total oxidation events (TOEs), whereby: for an
mC substrate, hmC represents one turnover, fC represents two turnovers, and caC represents
three turnovers (Figure 3-1C). Following that same logic, the TOE can be calculated for hmC and
fC substrates as well. By normalizing the data to that of mCpG, we see that mCpA only
experiences 37% of the oxidation events that mCpG does, with mCpT having only 21% (Figure 31D). Interestingly, when we compare the amount of mCpG oxidation to that at a mCpT on the
same single-strand of DNA, the preference for mCpG persists for the full catalytic domain of
TET2, as well as TET1 (Figure 3-3).
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Figure 3-2. TET2 activity on XpY-containing substrates in limiting enzyme
conditions.
Activity of 0.75 uM TET2-CS incubated with 1 uM XpY-containing DNA, with the
exception that data for mCpA is not included. A) Reaction products were
quantified by LC-MS/MS and expressed as the percentage of each base relative
to the amount of total modified cytosine. The reaction products of each sample in
A) are expressed as total oxidation events (TOE) using the respective equations
in Figure 3-1C. B) TOE are normalized to the respective maxima of oxidation
events and then presented relative to mCG
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Figure 3-3. TET1 and TET2 have greater activity on mCpG than mCpT in the
same single-stranded DNA substrate.
The TET reactions in these experiments were carried out as detailed in Chapter
2 (See section 2.5.3) but with 250 nM of either the mCpG/mCpG or mCpG/mCpT
oligomer substrate (CTAGCACmCGGTAGAATTCAGGCmCYTACGCCAATCT,
Y=G or T) and 250 nM of TET1-CD or TET2-CD. A) Restriction enzyme-, gelbased assay for detection of oxidation at two mC sites on the same DNA strand
(See Chapter 4, Figure 4-6 and Methods subsection 4.4.5 for more details). B)
Relative levels of oxidation by TET1 and TET2 on a single-stranded DNA with
either two mCpG sites or a mCpG at Site 1 and a mCpT at Site 2. Importantly the
“-TET” cleavage controls samples were both fully cleaved by HaeIII at Site 2 (not
shown).
In agreement with previous studies, the double-stranded mCpG-containing substrate is
also more reacted by TET2-CS than the hmCpG-containing substrate. Surprisingly, however,
hmCpG is of similar reactivity to the hmCpH substrates, with the proportion of remaining hmC
substrate being within 16% for all sequence contexts (Figure 3-1B). Further, the hmCpHs all
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convert nearly as well as the mCpH substrates, evidenced by both their similar substrate
consumption (Figure 3-1B) and TOE relative to mCpG (Figure 3-1D). Importantly, the ratios of
relative TOE of hmCpH substrates to their mCpH counterparts exceed 0.68, nearly doubling that
of the ratio of hmCpG to mCpG, which is 0.39 (Figure 3-1D). Finally, fCpG is not an efficient
substrate, but converts about twice as efficiently as each of the fCpH substrates, which are
minimally reacted (Figure 3-1C). These trends are consistent even when a more limiting amount
of enzyme is used, and 43% of the mCpG substrate remains unreacted (Figure 3-2).
3.2.1: Impact of +1 base on TDG excision activity
To assess the likelihood of active demethylation occurring from mCpHs, we also wanted
to investigate the impact of the +1 base on rates of TDG excision of fC and caC. Using the same
substrate series as the TET experiments above, single turnover kinetics experiments were
performed with TDG on G•T, G•fC and G•caC-containing substrates under saturating enzyme
conditions. Importantly, this allows us to operate under the assumption that the rate constants are
not impacted by substrate engagement, product release, or product inhibition; thus, the observed
rates of excision reflect the maximal rate of product formation. As previously published, TDG
excision of T is greatest with G at the +1 base (G•TG), exhibiting a 75-fold difference in activity
over the least active substrate, G•TT (Dow et al., 2019) (Figure 3-2, Table 3-1). Also, fC and caC
are both efficient substrates for excision by TDG, with caCpG excised at a similar rate to T, while
the rate of fCpG excision is 2-fold greater. Surprisingly, TDG does not exhibit the same level of
discrimination against fC or caC when in a CpH context as it does against T: Compared to fCpG,
the kmax is only reduced by 1.4-, 1.8-, and 4.7-fold for fCpA, fCpC, and fCpT, respectively.
Compared to caCpG, the kmax is only reduced by 1.3-, 1.7-, and 3.4-fold for caCpA, caCpC, and
caCpT, respectively (Figure 3-2, 3-5, Table 3-1). Therefore, TDG appears to be relatively
unaffected by the identity of the +1 base.
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Figure 3-4. Excision activity of TDG on mispaired T, fC, or caC in XpY
dinucleotides.
Excision rates (kmax) were determined from fitting curves of product accumulation
over time (Figure 3-5). Values are reported in Table 3-1.

Figure 3-5. Excision activity of TDG on fC, or caC in XpY sequence context.
Single turnover kinetics experiments were performed at 37 °C using a saturating
concentration of TDG. Data were fitted to a single exponential equation and the
resulting rate constants (kmax) are shown in Table 3-1. The corresponding curves
for excision of G•TY have been previously published in (Dow et al., 2019).
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Substrate

kmax (min−1)

kmax relative to XG

TG
TA

0.65 ± 0.03
0.063 ± 0.008

10

TC

0.029 ± 0.0007

TT

0.0087 ± 0.0006

22
75

fCG

1.31 ± 0.08

-

fCA

0.97 ± 0.08

1.4

fCC

0.74 ± 0.11

fCT

0.28 ± 0.02

1.8
4.7

caCG

0.57 ± 0.04

-

caCA

0.44 ± 0.03

1.3

caCC

0.33 ± 0.04

1.7

caCT

0.17 ± 0.01

3.4

Table 3-1. Relative rates of excision by TDG.
The kmax (kobs) values are the mean and standard deviation for at least three
independent single turnover kinetics experiments, at 37 °C. These values are
graphed in Figure 3-2 on a log scale.
3.3: Discussion
The biochemical experiments presented here expose the relative tolerances of both TET
and TDG for CpH contexts. In the conditions tested, TET2 exhibits a preference for mCpG, but
displays much greater activity on the mCpH contexts than previously observed with TET2-CS
(Hu, L. et al., 2013). Surprisingly, TET2 does not similarly discriminate against hmCpH substrates
compared to hmCpG. In general, hmCpH and hmCpG, as well as mCpH, are oxidized to a similar
extent. Meanwhile, TDG excision of fC and caC proceeds with relatively little dependence on the
identity of the +1 base, suggesting that TDG can process fC and caC generated for DNA
demethylation regardless of context.
3.3.1: Possible mechanisms of TET regulating observed substrate preferences
By analyzing our gel-based data and the available crystal structures, we can speculate
about the underlying mechanisms regulating the sequence preferences of TET observed here.
First, in addition to the LC-MS/MS data, a TET oxidation experiment was performed with two
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substrates each containing two mCs on the top strand; one substrate has two mCpGs while the
other has one CpG and one CpT (Figure 3-3). In the tested conditions, TET2 oxidized each
mCpG site to a greater extent than the mCpT, even when on the same strand of DNA. This result
illuminates possible mechanisms driving the relative substrate preferences of TET2 for mCpG
over mCpH. First, the finding that substrate preference is maintained even when there is not a
complement strand present seems to contradict the notion proposed from the crystal structure
that TET contacts opposite base paired with the +1 base, driving CpH discrimination. Second,
considering that base-stacking interactions are maintained even in single-stranded DNA, one can
imagine that the CpG base-stacking interaction, which is known to be the strongest of any
dinucleotide pair, aids in mC substrate engagement in some way that results in enhanced activity.
Meanwhile, we can also gain insight into the relative tolerance of hmCpH compared to
hmCpG by analyzing the crystal structures of TET2-CS in complex with either mC- or hmCcontaining DNA. In the hmC-containing structure, TET2 makes additional contacts with the
phosphodiester backbone surrounding the flipped-out base compared to the similar structure with
mC. If we consider our hypothesis from above that the strength of the base-stacking interaction is
important, one can envision a scenario in which the balance of contributing forces results in
relatively similar hmCH versus hmCG oxidation. There is precedent to support this general
hypothesis. Using molecular dynamic simulations, we have previously shown that changing the
target deoxyribo-mC to ribo-mC in a model of the crystal structure results in an altered H-bond
network between TET2 and the DNA backbone surrounding the target base. Interestingly, this
simulated change in interactions correlated with decreased activity on ribo-mC (DeNizio et al.,
2019).
For TDG, there is some kinetic data to suggest a mechanism for the observed fC and
caC sequence tolerance. Previously, using

19F

NMR method, it was shown that regulation of

thymine excision by the +1 base largely manifests by restricting flipping of thymine into TDG’s
active site (Dow et al., 2019). Uracil, meanwhile, appeared to stably flip into the active site of TDG
for all UpX contexts. Current 19F NMR methods can only detect the non-flipped state if it is ~5% of
the total signal. Although it is possible that small differences in flipping equilibria contribute to the
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differences in kmax, it is more likely that the small differences in kmax are due to post-flipping
mechanisms, such as formation of a productive enzyme-substrate complex and/or the chemical
steps of the reaction. Unfortunately, nucleotide-flipping equilibria for fC and caC are currently
unknown. Also, the environment of fC and caC in TDG in their respective crystal structures
(Pidugu et al., 2016; Zhang, L. et al., 2012) is not likely to be very informative because it is only a
snapshot of the most stable conformation. Thus, NMR or molecular modeling experiments in the
future will be useful in determining if TDG activity on fC and caC is unaffected by the +1 base due
to enhanced nucleotide-flipping.
3.3.2: Biological implications
Considering that TET activity on mCpH is relatively robust, even when activity is limited
on mCpG (Figure 3-2), the notion that TET is intrinsically resistant to oxidizing mCpH does not
seem likely. Further, our biochemical data shows that for every mCpH reacted to hmCpH, a
greater proportion of those hmCpHs are converted to fC/caC than the proportion of hmCpG
generated from mCpG. The fact that TDG is largely agnostic to the identity of the +1 base
supports the idea that the fCpH/capCH generated in this scenario can be ultimately replaced by
unmodified cytosine. Thus, from our data it is seems likely that the lack of hmCpH observed in the
genome is due, in part, to greater relative turnover by of hmCpHs by TET (Figure 3-6).
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Figure 3-6. Model of modified cytosine conversion, based on intrinsic
enzyme preferences, to explain depletion of hmCpH.
The biochemical data presented here supports a model in which hmCpH and
hmCpG are equally oxidized by TET and subsequently excised by TDG, despite
a strong preference for mCpG oxidation over that of mCpH. This would result in
relatively greater proportions of hmCpGs and mCpHs.
It is still possible, however, that disfavored mCpH oxidation is partly responsible for the
lack of hmCpH observed in vivo. It seems unlikely that differential localization would be
responsible because that the majority of mCpH occur near mCpGs (Lee, J. H. et al., 2017).
However, the lack of in vivo hmCpH may be due to either mCpH-specific proteins that block
oxidation, similar to methyl-CpG binding proteins, or a lack of hmCpH-specific proteins,
considering that hmCpG-specific proteins do exist (Spruijt et al., 2013). Also, it could be possible
that other domains of TET located in the N-terminal domain regulate a preference for hmCpG that
we do not observe in these experiments using only the catalytic domain; one could imagine a
mechanism similar to how the CXXC and BAH1 domains within DNMT1 inhibit methylation of
unmethylated CpGs (Song, J. et al., 2011).
In the future, we plan on confirming the biochemical similarity of TET on hmCpG and
hmCpHs with a second, non-MS based assay. In addition, although a TET-TDG-BER pathway
has been reconstituted from mCG in vitro, we would like to show that this is also biochemically
feasible at CpHs, as well.
3.4: Methods
The oligonucleotides and TET proteins used in this Chapter, as well as the LC-MS/MS
methods, were prepared as detailed in Chapter 2 (See sections 2.5.1, 2.5.2, and 2.5.4,
respectively).
3.4.1: TET reactions on XpY-containing substrates
The reactions performed prior to downstream analysis by LC-MS/MS were carried out as
detailed in Chapter 2 (See section 2.5.3), but in this chapter, specifically, 1 μM substrate was
incubated with either 1.5 μM or 0.75 μM of purified hTET2-CS (Figure 3-1 and 3-2, respectively).
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3.4.2: TDG protein expression and purification
TDG was expressed and purified by the laboratory of Alexander Drohat at the University
of Maryland, as previously described (Coey et al., 2016; Maiti et al., 2009). The enzyme
concentration was determined measuring absorbance at 280 nm, using an extinction coefficient
of ε280 = 17.4 mM−1cm−1.
3.4.3: TDG excision assay
The excision activity of TDG on fCpY- and caCpY-containing substrates was monitored in
a manner similar to previous studies (Dow et al., 2019). Briefly, the experiments were performed
under saturating enzyme conditions ([E] > [S], [E] >> KD), so that the rates observed (kobs) are
reflective of the maximal rate of product formation (kmax). Reactions were initiated by adding TDG
to 0.5 µM of DNA substrate in HEN.1 buffer (0.02 M HEPES pH 7.5, 0.1 M NaCl, 0.2 mM EDTA)
at 37 °C. At each timepoint, aliquots were removed and immediately quenched by adding 50%
(v:v) quench solution (0.3 M NaOH, 0.03 M EDTA). The samples were then heated for 5 min at
85 °C to cleave the DNA backbone at abasic sites quantitatively. The resulting DNA fragments
allowed for quantification of substrate and product by HPLC. Rate constants were determined
from fitting progress curves (Figure 3-5) to the equation, A(1–exp(–kobst)) using non-linear
regression (A is the amplitude, kobs is the rate constant, and t is the reaction time).
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CHAPTER 4: Examining TET-oxidized clusters of oxmCs in vitro and the possible
contributing mechanisms intrinsic to TET
4.1: Introduction
CpGs represent less than 1% of the dinucleotides in the human genome but are often
highly clustered. Cytosine methylation in these clustered CpG motifs has been studied
extensively, with an emphasis on the transcriptional regulation of regions that are differentially
methylated across development and in disease. These CpGs are often in localized, clustered
regions (which can include CpG Islands or CGIs) and are referred to as differentially methylated
regions (DMRs) (Deaton and Bird, 2011; Wang, L. et al., 2014). DMRs represent hotspots of
methylation dynamics, which are critical for genomic imprinting and regulation of gene expression
during development), as well as in many diseases (Bergman and Cedar, 2013; Smith and
Meissner, 2013). A major effort in the field has been to understand how and why cytosine
modifications are introduced or maintained, particularly within these dynamic regions.
As is the case with differential methylation at DMRs, TET-oxidized bases also cluster at
specific loci on both a population (Booth et al., 2012; Sun et al., 2015; Wen et al., 2014; Yu et al.,
2012) and single-cell level in vivo. For TET enzymes, oxmC clustering could be limited by either
the underlying CpG signature or the available mC bases at those CpGs. Although there is some
overlap with methylated regions, the distribution of hmC is unique such that it cannot solely be
explained by mC availability (Pastor et al., 2011). Notably, when TDG is knocked down in ES
cells, the higher order TET modifications fC and caC are also enriched in localized clusters,
including at unmethylated CGI promoters (Neri et al., 2015; Wu, H. et al., 2014).
In order to eventually contextualize the impact of external clustering factors on the
observed signature of oxmCs in vivo, we wanted to first assess the intrinsic capacity for TET to
generate clusters of oxidized modifications in a pared-down reaction environment, beginning with
substrates homogenously CpG methylated. To do so, we needed a way to localize multiple
oxmCs on large stretches of DNA, so we decided to utilize a single-base resolution sequencing
technique.
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There are several sequencing methods that are now regularly used to assess the oxmC
content of DNA. While there are many variations depending on the specific modified base of
interest (Wu, H. and Zhang, 2015), those that could prove most useful to us in this chapter are
reviewed below (Figure 4-1). In general, each of these methods exploits the differential chemical
or enzymatic reactivity of cytosine bases. The resulting bases are identified on individual
sequencing reads and aligned to a reference genome. The localization of a modified cytosine is
“called” when the frequency of that oxmC at a particular base exceeds a pre-designated
threshold, typically 20%. Thus, the reported signature of a particular oxmC is only representative
of the population average.

Figure 4-1. Chemical and Enzymatic Deamination-based sequencing
methods for localizing specific oxmCs.

Bisulfite (BS) sequencing is considered the gold standard for detecting mC; bisulfite can
chemically deaminate C, but not mC, to U, which is read as T by current sequencing platforms.
Upon the discovery of hmC, it was shown that although bisulfite creates a sulfonated product with
hmC (referred to as CMS), it is also read as C during sequencing (Huang, Y. et al., 2010). In
contrast, fC and caC are deaminated by bisulfite and converted to U (Wu, H. and Zhang, 2015).
Thus, both mC and hmC are read as “non-converted” C, while unmodified C, fC, and C are
converted and read as T in sequencing.
To identify hmC specifically, separate from mC, TET-assisted bisulfite sequencing (TABseq) was developed (Yu et al., 2012). In this method, hmC is first glucosylated (to ghmC) via T4
65

β-glucosyltransferase (βGT). Then, TET is used to oxidize mC to either fC or caC, which, like C,
can be converted by bisulfite. Meanwhile, ghmC is protected from TET oxidation and remains
unconverted by bisulfite and is thus the only base read as C upon sequencing. Another bisulfitebased method for hmC-specific detection is oxidative bisulfite sequencing (oxBS-seq) (Booth et
al., 2012). In this method, an oxidant, typically potassium perruthenate (KRuO4), is used to
chemically oxidize hmC to fC, to then be converted by bisulfite. A BS-only experiment is also
performed on the sample in tandem to identify the true C signal; this is then subtracted from the
oxBS-seq signal so that true hmCs may be called. Our lab has developed an enzymatic-based
method for specifically localizing hmC (Schutsky et al., 2018). In APOBEC-coupled epigenetic
sequencing (ACE-seq), hmC is also protected by glucosylation via βGT, then single-stranded
DNA is generated via snap-cooling so that C and mC can be deaminated by the APOBEC3A
enzyme. Notably, each of these methods was developed for analysis of genomic DNA, where fC
and caC typically occur at very low levels (Wu, H. et al., 2016), so they are not thought to obscure
the interpretation of hmC levels. However, for our purposes, we anticipated in vitro generation of
fC and caC at relatively high levels, so oxBS-seq was identified as the best method for identifying
clusters of oxmCs, as it yields deamination as a single readout for all three oxmCs on single
sequencing reads.
In addition to assessing TET’s ability to elicit clusters of oxmCs, in this chapter, we also
wanted to explore the mechanism by which this behavior could be mediated, specifically testing if
TET is intrinsically capable of acting processively on a strand of DNA. The processivity of DNAmodifying enzymes is defined as the capacity to repeatedly catalyze sequential reactions without
releasing their substrates (Van Dongen Stijn F M et al., 2014). This can refer to sequential activity
at multiple sites (strand processivity), or, unique to TET enzymes, the capability of iterative
oxidation, i.e. repetitive activity at a single site, which is also often referred to as catalytic
processivity. Our lab showed that mouse TET2 can act iteratively on a substrate with a single
mC, generating fC and caC in a single encounter (Crawford et al., 2016). However, another group
proposed that human TET1 and TET2 and N. gruberi TET1 do not exhibit strand nor catalytic
processivity but act distributively (Tamanaha et al., 2016). However, the experimental design and
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activity levels of their recombinant enzymes were not sufficient to discern between strand
processive or distributive mechanisms. Thus, the processive capacity of TET enzymes remains
unresolved, as does the interplay between catalytic and strand processivity. In this chapter, I
utilized measurements that allowed me to negate the possibility of catalytic processivity for the
time being because I assess all three oxmCs as “product.”
Classic studies of DNA-modifying enzymes, such as DNMTs (Holz-Schietinger and
Reich, 2010; Vilkaitis et al., 2005), restriction endonucleases (Jeltsch et al., 1996), and DNA
repair enzymes (Stivers and Jiang, 2003), provide precedent for enzymes with processive
mechanisms that underlie the generation of clustered products. Functionally, strand processivity
encompasses facilitated diffusion mechanisms of both 1D diffusion (sliding) and short hops/jumps
(Halford and Marko, 2004; Stanford et al., 2000). In contrast, enzymes that act distributively
randomly catalyze reactions following the association/conversion/dissociation pattern mediated
by 3D diffusion. While distributive enzymes often accumulate products slowly over time or as the
result of localized cellular density, processive enzymes can mediate concerted product
accumulation by catalyzing reactions over a few or up to thousands of bases with enhanced
speed and efficiency (Breyer and Matthews, 2001).
Features revealed in the crystal structure of human TET2 bound to 5mCpG-containing
DNA (Hu, L. et al., 2013) suggest that TET belongs to the family of processive enzymes. As
discussed in previous chapters, TET engages its catalytic substrate via a base-flipping
mechanism, with specific residues contacting the cytosine base. Strikingly, all other interactions
with DNA appear non-specific: a hydrophobic ridge inserts into the minor groove and a number of
residues form a network of hydrogen bonds and electrostatic interactions with the phosphodiester
DNA backbone. This structure is reminiscent of other processive DNA modifying enzymes, which
are thought to maintain electrostatic interactions with DNA during sliding; upon target site
recognition, these enzymes rearrange to form stronger interactions to initiate catalysis. Although
the mechanisms of substrate recognition and engagement are still unresolved, the structure does
support the possibility that TET can act processively.
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In this chapter, I therefore aimed to address two questions regarding the intrinsic
capabilities of TET. First, what is the extent of clustering elicited by TET in vitro? Second, can
TET act processively? Addressing both questions presented the similar challenge of how to link
the information between two or multiple mCpGs. This objective required the development of both
unique metrics for quantifying oxmC clustering and a novel, gel-based assay for assessing TET
processivity. Although each of these questions remain somewhat unresolved, both experimental
approaches yielded other insights into possible mechanisms of TET substrate regulations.
4.2: Results
4.2.1: Capacity for TET-generated oxmC clustering in vitro
To first assess the extent of clustering intrinsic to TET, we performed in vitro reactions
with the full catalytic domain of either TET1 or TET2 on a 2.7 kb enzymatically-CpG-methylated
double-stranded pUC19 substrate. An advantage of this substrate is that there are no
unmethylated CpGs to complicate the interpretation of the sequencing data. The original plan was
to use oxBS-seq to analyze TET activity because this method would allow us to localize
unreacted mCpGs and reacted oxmCs separately. Although we did achieve eventual success in
optimizing the assay (Figure 4-2), most of the data collected was analyzed using a BS-seq
protocol. Although we are unable to separately detect mC and hmC, we can analyze the
clustering of the higher oxidized modifications, fC and caC (hoxmCs), together. We performed
numerous experiments in which we varied both the TET concentration and incubation time, and in
each instance saw varying degrees of clustering (Figure 4-3).

68

Figure 4-2. Preliminary experiment using oxBS-seq to localize TET1generated hmC, fC, and caC together, separately from mC.

Figure 4-3. TET1 and TET2 mediate clusters of hoxmCs from
homogenously CpG-methylated single strands of DNA
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An exemplary set of TET2-reacted, BS-converted data is shown in Figure 4-4. In the grid
in Panel A, each row represents the data from a single Sanger sequencing read of a single clone
from a particular DNA molecule. The boxes in each column represent the 28 CpGs in the 362base-pair PCR-amplified region that was sequenced. The DNA experienced varied levels of TET
oxidation and exhibited varying levels of clustering (Figure 4-4A). Qualitatively, for the clones with
nine hoxmCs or less, there are several instances in which two oxmCs occur at neighboring CpGs.
Meanwhile, for clones with eleven or twelve oxidation events, one can observe instances in which
4-7 hoxmCs occur in a row on a particular DNA strand (Figure 4-4A).

Figure 4-4. TET2 generates clusters of hoxmCs on a fully CpG-methylated
substrate.
A) Localization of hoxmCs (fC/caC) on DNA from a single TET reaction. Each
row represents the data from a single Sanger sequencing read, representing a
single molecule of DNA, and each box represents a single CpG site. There are
28 CpGs in the 362 bp region analyzed. In the included data, all CpH were
successfully converted by bisulfite, but that is not represented here.
B) Comparison of the number of hoxmCs with at least one neighboring hoxmCs
in either direction between the dataset in A) and a randomized data set, for each
individual DNA strand. C) Clustering scores for each relative pair of CpGs, with
the average score for the 27 CpG pairs indicated by a blue dashed line. The red
dashed line at the clustering score of 1 delineates the threshold for which
clustering is considered to occur at a non-random frequency.
In addition to this qualitative assessment, we have also developed metrics by which
clustering can be measured semi-quantitatively (Figure 4-4B) and quantitatively (Figure 4-4C).
Although the larger stretches of clustered hoxmCs are inarguably significant, we have determined
that it is both easier but still effective to quantify the non-random nature of the clustering on a twoCpG-site scale. First, for different levels of overall activity, we can assess the number of hoxmCs
that occur with an hoxmC at either neighboring CpG (Figure 4-4B). Further, by generating a
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horizontally randomized data set, we can determine whether the frequency of neighboring
hoxmCs occurs to a greater extent in the actual data set than by chance. Although there is an
outlier for the sample that has eleven hoxmCs, in general there are less hoxmC sites with
oxidized neighbors in the randomized data set than the actual TET2 dataset. We have also
developed a metric to assign each CpG a clustering score. This score compares the observed
frequency at which two hoxmCpGs occur next to each other to the frequency at which the event
is likely to occur due to the underlying, supposedly-unlinked reactivities at each CpG site
individually. If the first CpG is designated CpG1 and the second CpG2, on a sliding scale from 5’
to 3’, then the clustering score can be written as:
_(Freq. of hoxmCs at both CpG1 and CpG2)_
(Freq. of hoxmCpG1) x (Freq. of hoxmCpG2)

(Eq. 1)

When the clustering score is greater than 1, it indicates that the observed clustering of
two hoxmCpGs occurs more frequently than probability would suggest based on their underlying
individual reactivities alone. In the dataset in Figure 2-1A, there is an average clustering score of
2.5. It should be noted that the rarity of oxmCs at each site has an impact due to the nature of the
metric. That is, if two neighboring CpGs are very frequently oxidized in most of the analyzed DNA
molecules, there is more likely to be a lower clustering score as there is a relatively high
probability that both CpGs will be oxidized. For example, even though CpG numbers 7 and 8 are
heavily modified in this particular data set (45% and 64%, respectively) and may appear to be
clustered by eye, CpG number 7 only has a clustering score of 0.94 because the frequency of
dual oxidation does not exceed the already high likelihood that both would be oxidized. In
contrast, CpG pairs that are not frequently oxidized but do occur in the same DNA molecule when
they are, such as CpG numbers 22 and 23, will have a relatively high clustering score. One
advantage of this score is that it implicitly accounts for any underlying preferences that TET may
have and provides an assessment of clustering independent from that.
We would have ultimately preferred to analyze a large dataset using oxBS-seq and nextgeneration sequencing, but there is utility in analyzing all of the data we have collected from
separate BS-seq experiments (Figure 4-3), so that we may benefit from improved depth when
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assessing the clustering capacity of TET1 and TET2. The criteria for the reads included were that
they 1) had hoxmCs at less than 50% of the CpG sites and 2) were from experiments in which the
unreacted mCpG control samples showed no detectable BS-conversion (data not shown).
Although there are a different number of sequencing reads included in the two data sets, both are
similarly reacted, with 17% and 21% hoxmC, respectively, of the possible sites reacted for the
TET1- and TET2-treated samples (Figure 4-3). When examining the total oxidation at each CpG
site, we see that TET1 and TET2 exhibit somewhat similar reactivity profiles (Figure 4-5A,B).
Despite this, TET2 has generated a greater proportion of clusters of three or more hoxmCs than
TET1 (Figure 4-3). Further, while there is only one cluster of four and one of five hoxmCs in the
TET1 data, there are several clusters of four to seven hoxmCs in the TET2 dataset. Also, in a
TET2-treated sample, when there are seven hoxmCs observed, six of those occur sequentially. In
addition to these qualitative observations, the clustering scores for these combined data sets
showed that TET2 has a slightly greater propensity to elicit clusters of hoxmCs than TET1 (Figure
4-5C,D); there are both fewer data points with scores less than 1 for TET2 compared to TET1,
and the average clustering score for TET2 is 2.1 compared to 1.4 for TET1.

Figure 4-5. Overall frequency of hoxmCs and clustering scores at each CpG
in TET1 and TET2 treated BS-seq samples.
A-B) Total hoxmCs observed at each CpG in the amalgamated BS-seq datasets
(Figure 4-3) of TET1- (A) and TET2- (B) treated samples. The grey boxes
indicate the upper and lower quartiles of the most and least reacted CpG sites,
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respectively. C-D) Clustering scores for each relative pair of CpGs in the TET1
(C) and TET2 (D) datasets, with the average score for the 27 CpG pairs indicated
by a blue dashed line. The red dashed line at the clustering score of 1 delineates
the threshold for which clustering is considered to occur at a non-random
frequency.
4.2.2: Measuring TET processivity
As mentioned previously, processivity is a common mechanistic feature of DNAmodifying enzymes that can act on sequential target sites. As utilized in the denominator of the
clustering score above, if an enzyme acts in a distributive manner, then the probability of two
oxidation events occurring is the same as the product of their independent probabilities (Figure 47A). To determine if TET can act processively, I designed a novel, enzyme-coupled assay that
allows me to quantify any/all oxidation at two neighboring sites on a DNA oligomer (Figure 4-6A).
Critically, the two mC sites are embedded in MspI and HaeIII modification-sensitive restriction
sites. MspI and HaeIII specifically cleave sequences containing mC, hmC, and fC but not caC. I
leveraged the lack of cleavage at caC, together with selective chemical protection of hmC and fC,
to interrogate the identity of the modifications at each site. Specifically, I incubate the substrate
with TET under conditions of low product formation to operate under the assumption that only one
TET enzyme interacts with one DNA molecule. I attach a bulky aldehyde reactive probe (ARP) to
fC (Koh et al., 2011) and then glucosylate hmC using T4 β-glucosyltransferase (βGT) (Terragni et
al., 2012) so that all TET reaction products (hmC, fC, and caC) are fully protected from restriction
cleavage, while unreacted mC is cleaved to give fragments of distinct lengths. By treating each
sample with MspI, HaeIII, or both restriction enzymes together and quantifying cleavage products
on a denaturing PAGE gel, I can compare the relative amounts of uncleaved DNA (i.e. oxidized
reaction products). Treating with one enzyme informs us of the frequency of oxidation at a single
site and using both enzymes tells us the frequency that oxidation occurs at two sites on the same
strand.
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Figure 4-6. R.E.-, gel-based assays for measuring oxidation at two mCpG
sites with the goal of assessing strand processivity

Using this assay, we analyzed reactions of substrate (1) with TET1 and TET2 (Figure 47B). At 1:1 DNA:enzyme, both TET1 and TET2 oxidize about half of the substrate molecules.
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Interestingly, the two mCpG sites are not equally reactive for either TET1 or TET2, varying by 2to 3-fold. Also surprisingly, the two TET enzymes exhibit different preferences for site 1 and site
2, with TET1 oxidizing more mC at site 2 and TET2 oxidizing more at site 1. For both TET1 and
TET2, the fraction of DNA with oxidation at both sites is proportionally similar to the fraction that
has oxidation at the less reactive site. This suggests that that oxidation at the two sites is often
linked, as there is not a large fraction of DNA with only the less reactive site oxidized.
Nevertheless, using the frequencies of oxidation at site 1 and site 2 separately, we can calculate
the likelihood that both sites would be oxidized if the enzyme were distributive. For both TET1
and TET2, the amount of DNA with both sites oxidized is greater than that of the theoretical
amount that the enzyme would “If Distributive,” suggesting that the enzymes are acting
processively in these assays.

Figure 4-7. TET1 and TET2 exhibit strand processivity when comparing
oxidation levels calculated using an indirect, R.E.-based assay
A) Cartoon scheme of simplified mechanisms for strand processive (left) and
distributive (right) oxidation, with corresponding mathematical probabilities. B)
Relative levels of oxmC products on substrate (1), measured at each site
separately and both sites simultaneously via a restriction enzyme-, gel-based
assay (see Figure 4-6A for details). The fraction of DNA with oxmC products at
each site separately are multiplied to generate the theoretical value for the
fraction of DNA that would have two oxmCs “If Distributive.”
In order to test for processivity, it is essential that conditions are such that allow for the
assumption that only one TET molecule interacts with one DNA molecule. Although the 1:1
DNA:enzyme conditions used are not ideal for making this assumption, we were limited by the
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sensitivity of the assay. Nevertheless, despite being confident our analysis of the data in Figure
4-7 is mathematically sound, we wanted to develop another assay to robustly prove that the TET
enzymes were acting processively.
Therefore, we performed a modified (but similar) gel-based assay (Figure 4-6) in tandem
with whole oligo ESI-MS analysis of the same TET-treated sample (Figure 4-8). In the modified,
gel-based assay, the two mCpG sites are each embedded within the target sequence of the MspI
restriction enzyme (Figure 4-8A, 4-6B). For ease of analysis, we only protected hmC from
cleavage prior to MspI digestion or MS analysis. Due to the design of the oligomer substrate, we
can only assess the fraction of DNA with hmC(s) at site 1 and both sites, but not that at site 2
alone (Figure 4-8A,C). By assuming an identical proportion of DNA contained hmC at site 2 as at
site 1, we were able to generate the theoretical fraction of DNA with hmCs at both sites if TET
were acting distributively (Figure 4-8B). Despite performing the reaction with a more limiting
amount of TET1 (2:1 DNA:enzyme), we observed a similar result to the previous assay: The
amount of DNA with oxidation at both sites was greater than what we would expect to see if TET
were acting distributively. Meanwhile, the whole oligo ESI-MS assay allowed us to detect masses
corresponding to the 1) unreacted, dually-methylated substrate strand, 2) a singly glucosylhydroxymethylated strand, and 3) a dually-glucosylhydroxymethylated strand (Figure 4-8D).
Assuming that the peak corresponding to a single glucosyl-hydroxymethylated strand represents
the proportion of sample with a ghmC at either site 1 or site 2, we can calculate the fraction of
DNA with a single hmC by dividing half of that signal by the sum of the signals from the substrate
peak (with two mC) and two product peaks (one ghmC and two ghmCs). Similar to the gel-based
assay, if we assume there are equal proportions of DNA with a single hmC at either site, we can
calculate the theoretical fraction of DNA that would have hmCs at both sites if TET were acting
distributively (Figure 4-8B). Unlike the gel-based method, however, in this assay the observed
and theoretical fractions of DNA with hmCs at both sites are relatively equal, suggesting that TET
is acting distributively. These conflicting results gave us pause and we decided that more rigorous
work needed to be done in order to confidently report whether the TET enzymes can act
processively.
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Figure 4-8. Comparison of a modified, gel-based and ESI-MS assays in
tandem yield conflicting results regarding TET1 processivity.
A) Experimental steps prior to tandem analyses of the same TET1-treated
sample by either a gel-based assay (C) or ESI-MS (D). The gel-based assay is
modified (See Figure 4-6B for details) from a similar method used to generate the
data in Figure 4-7 and 4-9. B) Relative quantification of hmC detected at either a
single or both sites via both detection methods. C-D) The raw data that is
quantified in (B). (C) Notably, this gel-based assay utilizes a single R.E., only
allowing for the accurate quantification of hmC at Site 1. To account for
incomplete cleavage, the “-TET1” values for fractions of DNA with hmC at Site 1
or Both Sites are subtracted from the “+TET1” values. (D) Prior to collecting this
data, we analyzed a control sample with equimolar ratios of mC/mC, ghmC/mC,
mC/ghmC and ghmC/ghmC substrates to ensure all were detected equally by
ESI-MS (data not shown).
4.2.3: Exploring sequence context preferences of TET enzymes
Despite the inconclusive result regarding processivity, we still wanted to pursue the
observation that the two mCpG sites in substrate (1) exhibited different reactivities from both each
other and for TET1 and TET2. To our knowledge, that a biochemical difference in substrate
preference has been observed for two of the human TET homologs. To explore the mechanistic
reason for this discrepancy, we designed two other substrates: In substrate (2), we flipped the
sequence in half in order to explore the effect of larger sequence context preferences; in
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substrate (3), we only flipped the restriction-enzyme target-sequences (Figure 4-9A). Similar to
substrate (1), TET1 and TET2 oxidize each mCpG site to different extents (Figure 4-9B).
Surprisingly though, TET1 and TET2 exhibit a similar, roughly 2-fold preference for site 2 in
substrate (2). With substrate (3), there are drastically different activity levels on site 2 for TET1
and TET2, with TET1 exhibiting about 2-fold greater activity. Thus, while TET1 appears to
consistently prefer site 2, TET2 shows more variability in its preferences.

Figure 4-9. Investigating the unequal reactivities of two mCpG sites on the
same DNA strand, via the original gel-based assay.
A) Three different substrates are used in the experiments in this figure to test
different hypotheses regarding the basis for the differences in oxidation at each
site. The color-blocking corresponds substrate (1) and is meant to highlight that
substrate (2) is completely flipped, while substrate (3) only switches the local
sequence context of the respective R.E. target sequences. B) TET1 and TET2
activity on substrates (2) and (3). C) TET2 activity on single-stranded substrate
(1). D) The relative oxidation levels of TET2 on each site measured in (B), as well
as Figure 4-7B, and the corresponding local Tm of the 6 surrounding bases. E)
TET2 activity on substrate (1) in concentrations of NaCl ranging from 0-200 nM.
While it remains unresolved if there are true substrate preference differences for TET1
and TET2, we were intrigued by the variability in site preference exhibited by TET2 and wanted to
explore this observation further. First, we incubated TET2 with single-stranded substrate (1) to
test the impact of the complement strand (Figure 4-9C). At various concentrations of TET2, the
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discrepancy between oxidation levels at the two mCpG sites is lost and each site is reacted to the
same extent. While the level of oxidation at both sites is no longer equal to that of the least
reacted site, it still occurs at a level higher than we would expect if TET were distributive. Also,
this finding suggests that base-pairing has an impact on the relative extent of oxidation that can
occur at a particular site. Considering this and that TET2 is a base-flipping enzyme, we
hypothesized that the local breathing of duplexed DNA could be a determining factor. To consider
this, we ranked the relative oxidation at each site for the three double-stranded substrates and
compared the local melting temperatures (Tm) of the +/-3 base regions surrounding each CpG
site (Figure 4-9D). Although the dataset is limited, there is a general inverse correlation between
oxidation level by TET2 and local Tm of the substrate.
To further explore the role of duplex DNA thermodynamics, we performed incubations of
TET2 with substrate (1) at various NaCl concentrations (Figure 4-9E). In all other instances,
reactions were performed at 100 nM NaCl, where there is 2.7-fold greater oxidation at site 1 over
site 2 for TET2 (Figure 4-7B, 4-8E). In this experiment, the reactivity at site 2 remains relatively
consistent for all NaCl concentrations, even with no NaCl in the reaction. Meanwhile, oxidation at
site 1 increases linearly with increasing NaCl concentration, effectively decreasing the
discrepancy between the two sites at lower NaCl concentrations (Figure 4-9E). Conventionally,
increases in salt concentration causes both an increase in DNA melting temperature and
decreased protein affinity for DNA. Therefore, we would have expected to see the opposite result
if TET’s ability to access the Watson-Crick face of the target mC or the strength of the
electrostatic interactions with DNA were primary factors regulating TET’s substrate preferences.
Despite the lack of clear mechanistic explanation for the variation in reactivity at two
mCpGs on the same oligomer, we were still intrigued whether the TET enzymes have a particular
sequence context preference, other than the preference of G at the +1 base. To assess this with
a greater sequence variation, we re-examined the BS-seq clustering data (Figure 4-3). Although
there are only 20 unique sequence contexts with regards to the region +/- 2 bases surrounding
each mCpG, I decided to examine the sequence contexts of the most and least reacted sites in
these samples (Figure 4-5A,B, grey boxes). For both TET1 and TET2, there is a stark trend: The
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most reacted mCpGs have A or T at the -1 base position, while the least reacted mCpGs
primarily have G (Table 4-1). This is not likely due to a lack of availability, as there are three times
as many mCpGs with G at the -1 position as there are with A (Table 4-2).

TET1
CpG #

TET2
-2

-1
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% hoxmCs per site
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Table 4-1. Sequence contexts of the most and least reacted mCpG sites in
the pUC19 BS-seq samples.

Sequence frequencies
Base
-2
-1 +2
A
4
4
2
T
10
8
4
C
6
4
12
G
8
12 10
Table 4-2. The base frequency directly surrounding the 28 mCpGs in the
362 bp, pUC19 region.
4.3: Discussion
The original goal of this project was to address both the extent to which TET can elicit
clusters of modifications and test for the most likely underlying mechanism, that TET can act
processively. Although unable to fully realize our goal of using oxBS-seq to analyze the clustering
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of all oxmCs generated on mCpG-containing DNA in vitro, we were able to generate data using
BS-seq to localize the higher oxidized modifications, fC and caC. The amalgamated datasets
consist of TET-treated DNA reads from a variety of reaction conditions with either TET1 or TET2.
We observe that both TET1 and TET2 elicit clusters of hoxmCs, in both a qualitative and
quantitative manner, despite generally low levels of overall activity. We developed the clustering
score to quantify clustering in a manner that takes the oxidation levels of each individual CpG site
into account, so that we may assess whether clustering occurs solely due to a greater underlying
preference for a particular stretch of CpGs or some additional factor. The finding that both TET1
and TET2 generate an average clustering score greater than 1 for the analyzed region of the
pUC19 substrate suggests that an additional factor may be involved. An important caveat of
these observations is that the trends may not be relevant when hmC generation is assessed both
separately from and together with fC and caC (as all oxmCs). Nevertheless, just as mC clustering
must impact hmC clustering so must hmC affect fC/caC clustering, so it is reasonable to predict
that hmCpGs will cluster as well.
Structural insight into the network of contacts between TET and DNA initially led us to
hypothesize that TET can act processively. We devised an indirect, enzyme- and gel-based
assay that allowed us to assess how frequently oxidation of two mCpG sites on the same
oligomer occurs in comparison to the likely frequency if the enzyme were only to act distributively.
For both TET1 and TET2, we observed about twice as much dual-oxmC product DNA as we
would expect to occur by chance. Despite this evidence for processivity, an alternative MS-based
assay performed in tandem with a modified, gel-based assay yielded conflicting results: While the
observed fraction of DNA with TET-generated hmCs at both CpG sites exceeds the likely fraction
if the enzyme were distributive in the gel-based assay, it does not in the MS-based assay.
In the absence of a clear finding regarding processivity, this work has still provided
several useful lessons. First, it highlights the importance of assay design. While unlikely that
either assay is “wrong,” it is an important reminder that rigorous quantification by multiple
methods is required prior to reporting a claim. Second, the gel-based assay provides a relatively
facile method for quantifying TET oxidation at two different sites and is the only TET biochemical
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experiment to do so, to our knowledge. Tamanaha et al. also examined the in vitro activity of
human TET1 and TET2 on multiple mCpGs but did so as a bulk measurement (Tamanaha et al.,
2016), rather than looking at the levels of each individual site.
The gel-based assay also allowed us to explore the unequal reactivities at the two
different mCpG sites. Although there was not a consistent pattern for TET1, there was some
indication that TET2 activity was impacted by local sequence context. Interestingly, when there is
no complement DNA strand and the substrate is single-stranded, TET2 oxidized both sites
equally, suggesting local base-pairing surrounding the target mC has a significant impact on
relative TET2 activity. In line with this theory, the overall preferences of TET2 for the relative
mCpGs in each of the three substrates loosely correlated with Tms for the region surrounding
each mC. However, TET2’s preference cannot be solely dictated by the thermodynamics of DNA,
as we observe increasing oxidation at site 2 with increasing salt concentrations. Despite this,
there is some initial evidence that local sequence context does play a role in TET oxidation
preferences, at least when it comes to fC and caC generation. Of the 28 CpGs in the analyzed
BS-seq reads, the most consistently oxidized sites are those with an A or T at the -1 position and
those that are the least frequently oxidized have G at the -1 position. Notably, however, each of
the mCpGs in the short oligomers substrates had C at the -1 position, yet differences in reactivity
were still observed.
There are limited previous biochemical studies to test the general sequence preferences
of TET, outside of the influence of the +1 base. For example, human TET2-CS has been shown
to have more activity on an AT-rich hm/fCpG-containing substrate than a CG-rich one of the
same length (Hu, L. et al., 2015). In addition, sequencing of mouse TET1-generated hmCcontaining sequences showed 3’ sequence specificity at both the +1 and +2 positions, with G and
C preferred at the former and a pyrimidine preferred at the latter (Kizaki, Seiichiro et al., 2016). In
ESCs, there is TAB-seq data that suggests hmC is enriched in G-rich sequences, but this does
not extend to the immediately upstream bases; TCA occur most frequently at the -3 to -1
positions (Yu et al., 2012).
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The idea that the general sequence context could be involved in regulating the epigenetic
regulation of gene expression would be quite radical; however, it is also clear that GC content
varies throughout the genome, which could impact local CpG melting. To that end, it would be
interesting to assess both the levels of oxmC clustering in specific genomic regions in various cell
types, as well as the relative sequence contexts of the detected oxmCs. Further, the knowledge
of both the clustering capacity and sequence preferences will be important for the development of
biotechnological tools that utilize TET. For example, if an ideal sequence context were to be
identified, it would be useful to embed an unnatural modified cytosine base in that sequence in an
activity-based probe (Ghanty et al., 2018). In addition, as epigenetic editing platforms progress
(DeNizio et al., 2018), it will be essential to understand the catalytic capacities of TET and other
DNA-modifying enzymes to have appropriate expectations for which sequences will be modified
and to what extent, once targeted there.
4.4: Methods
The TET proteins used in this chapter were expressed and purified as detailed in Chapter
2 (See section 2.5.2).
4.4.1: Substrate preparation
All DNA oligonucleotides were purchased from Integrated DNA Technologies (IDT), with
the exception of the hmC-containing control oligomers (Figure 4-8), which were purchased from
Yale Keck Oligonucleotide Synthesis facility. The substrate oligonucleotides, containing modified
cytosines, were fluorescently labeled at the 3’ end with 6-carboxyfluorescein, with the exception
substrate (3), which was 5’-Cy5- and 3’-Cy3-labeled. The complement oligonucleotides did not
contain modified cytosines and were unlabeled. All oligonucleotides were HPLC purified and the
masses confirmed. All substrates were diluted to 5 or 10 μM (of reactive, methylated substrate,
whether single- or double-stranded), prior to use in TET reactions. Duplexed oligos were
annealed at ratios of either 1:1.2 or 1:1.5 substrate:complement by heating to 95 °C for 3 min and
cooling slowly to 4 °C.
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For the clustering experiments, methylated and non-methylated pUC19 DNA was
purchased from Zymo Research and is 1 ng/uL. The non-methylated pUC19 DNA was isolated
from a methylation-negative strain of bacteria (Dam–, Dcm–). The methylated pUC19 DNA was
isolated from the same strain and was then enzymatically methylated at all CpGs by M.SssI
methyltransferase. Both pUC19 DNA samples were linearized at position 2177 using ScaI
endonuclease.
4.4.2: TET reactions on methylated pUC19 DNA
The mCpG-containing pUC19 substrate was diluted in reaction buffer (50 mM HEPES,
pH 6.5, 100 mM NaCl, 1 mM α-KG, 1 mM DTT, and 2 mM sodium ascorbate) so that 100 pg was
reacted. Fresh ammonium iron(II) sulfate (Sigma) was added to 75 μM prior to initiation, and
purified enzyme, at concentrations ranging from 6-800 nM, was added last to start the reaction (t
= 0), bringing the total volume to 25 μL. The reactions were incubated at 37 °C for times ranging
from 45 min to 3 hrs. Reactions were quenched by addition of pre-mixed quenching solution (25
μL H2O, 100 μL Oligo Binding Buffer (Zymo), and 400 µL ethanol) and then purified using the
Zymo Oligo Clean & Concentrator kit and eluted in 15 μL of Millipore water.
4.4.3: Bisulfite-sequencing analysis of TET-treated pUC19 DNA
To localize fC and caC in the product pUC19 DNA, bisulfite sequencing was performed
using the Epitect Bisulfite Kit (Qiagen). The FFPE protocol was followed, with a longer, 10 hour
PCR protocol, in order to minimize mC conversion and maximize fC conversion (Wu, H. et al.,
2016).
A 362 base-pair region was amplified from the 2.7 kb pUC19 DNA using bisulfite-specific
primers that did not contain any CpGs (forward primer, GGTTATAGTTGTTTTTTGTGTGAAATT
GTTATT; reverse primer, CTAACCTTTTACTCACATATTCTTTCCTAC) and allowed for
visualization of a single strand of the double-stranded pUC19 substrate. For the PCR reaction, 1
µL of Epimark Hot Start Taq DNA Polymerase was mixed with 1X of the supplied reaction buffer
and 200 µM of each dNTP, and an optimized PCR method was used (95 °C for 30 s, 40x[95 °C
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for 15 s, 58 °C for 30 s, 68 °C for 30 s], 68 °C for 5 min. PCR products were run on a 1.3%
agarose, ethidium bromide gel; the 362 bp product band was excised, purified using the Gel DNA
Recovery Kit (Zymo), and eluted in 8 µL Millipore water.
TA cloning was performed so that individual DNA molecules could be analyzed. Using
the TOPO TA Cloning Kit (Invitrogen), 4 µL of the amplicon was mixed, immediately after gel
purification (to maintain 3’-thymine overhangs), with 1 µL salt solution and 1 µL pCR4 vector. The
reaction was incubated at room temperature for 30 min-1 hr. Then, 3 µL of the reaction was
transformed into Turbo Competent E. coli cells (NEB), using a heat shock at 42 °C for 45 s,
immediately followed by a 2 min incubation on ice. SOC Broth was added to the cells, and the vial
was rotated at 37 °C for 1 hour. The cells were spun down at 9,000 rpm for 5 min, resuspended
in 100 µL, and then plated on a KanR/Xgal LB agar plate for incubation at 37 °C for 16 hours and
then at room temperature for 8 hours. Individual clones were isolated, cultured, and the plasmid
purified using the QIAprep Spin Miniprep kit (Qiagen).
The purified plasmids were sent to GeneWiz (South Plainfield, NJ) for Sanger
sequencing analysis. The M13(-21) forward primer was used to visualize the inserted amplicon.
Samples in which all CpH were converted to TpH (i.e. complete bisulfite conversion) were
analyzed for CT conversion against the amplicon reference sequence.
4.4.4: TET reactions on oligonucleotides
For most of the reactions on the two-mC-containing oligomer substrates, substrates were
diluted to 250 nM in the same reaction buffer (50 mM HEPES, pH 6.5, 100 mM NaCl, 1 mM αKG, 1 mM DTT, and 2 mM sodium ascorbate). Fresh ammonium iron(II) sulfate was added to 75
μM prior to initiation, and 250 nM purified enzyme was added last to start the reaction (t = 0),
bringing the total volume to 25 μL. There were three experiments for which these conditions
varied slightly: For the experiment in Figure 4-8, 500 nM substrate:1 uM enzyme was used. For
the experiment in Figure 4-9C, TET2 was reacted at concentrations ranging from 30-250 nM. For
the experiment in Figure 4-9E, NaCl concentrations of the reactions varied from 0-200 nM. All
reaction mixtures were incubated at 37 °C for 40 min. Reactions were quenched by addition of
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pre-mixed quenching solution (25 μL H2O, 100 μL Oligo Binding Buffer (Zymo), and 400 µL
ethanol). Oligonucleotide products were purified using the Zymo Oligo Clean & Concentrator kit
and eluted in 8 μL of Millipore water.
4.4.5: Restriction-enzyme, gel-based analysis of TET-treated oligonucleotide DNA
A graphical representation of the following protocols is shown in Figure 4-6. Prior to
downstream analysis, single-stranded DNA was annealed to complement by heating at 95 °C for
3 min then slow-cooling to room temperature (experiment in Figure 4-9C). For the original assay
design, in which two different R.E. are utilized (Figure 4-6A), a fC protection step was included in
which 4 µL of purified product DNA was diluted into 6 mM HEPES, pH 5 and mixed with 15 mM
ARP (Dojindo Molecular Technologies, then Gold Biotechnology, then Cayman Chemical). The
10 µL reaction was incubated at 37 °C for 3 hours. Then, for hmC protection it was diluted directly
into CutSmart Buffer, mixed with 2 mM of uridine diphosphoglucose (UDP-Glc) and 1 µL of T4
Phage β-glucosyltransferase (NEB), and incubated at 37 °C for 1-2 hours. The 15 µL reaction
was then split in triplicate and incubated with either 1 µL of MspI (NEB), 2 µL of HaeIII (NEB), or a
total of 3 µL of both enzymes in 10 µL reactions; these restriction digestions were performed at
37 °C for at least 4 hours. The reaction products were mixed 1:1 with formamide containing
bromophenol blue loading dye, heated at 95 °C for 15 minutes, then loaded onto a 7M urea/20%
acrylamide/1X TBE gel prewarmed to 50 °C. The gel was imaged for either FAM, Cy3, or Cy5
fluorescence on a Typhoon FLA9500 imaging system (GE Healthcare).
For the modified version of this assay (Figure 4-6B), only the hmC protection step was
performed, so the purified reaction products are diluted into Cutsmart and mixed with 2 mM UDPGlc and 1 µL T4 BGT in a reaction volume of 10 µL; it was incubated at 37 °C for 1 hour. The
reaction was then ethanol precipitated and resuspended in 10 µL Millipore water. For restriction
enzyme digestion, 1 µL of the sample was diluted into CutSmart Buffer, mixed with 1 µL MspI in a
final reaction volume of 10 µL, and incubated at 37 °C for 4 hours. The reaction products were
analyzed in the same manner as above. For ESI-MS analysis, the other 9 µL (containing ~2 uM
DNA) was sent to Novatia (Newtown, PA).
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CHAPTER 5: Conclusions & Future Directions
In summary, this thesis has exposed previously unexplored substrate preferences of
human TET enzymes. As biochemists, we are committed to the belief that knowledge of TET’s
intrinsic reactivities is crucial to contextualizing the biological functions of observed oxmC
signatures in the genome. By quantifying the steady-state products generated on different
nucleic acid structures via LC-MS/MS, we have identified that TET2 is more promiscuous on
different nucleic acid structures than originally thought, and that the nucleic acid identity of the
target base itself is the strongest determinant of TET activity (Chapter 2). We also examined
the activity of TET on dsDNA with each of the three possible modified cytosine substrates in
CpG versus CpH sequence contexts. Despite exhibiting the expected preference for mCpG,
TET2 exhibits more tolerance for hmCs when in a CpH context, providing a possible
mechanism to explain the depletion of hmCpH observed in cells with relatively high mCpH
levels (Chapter 3). Finally, by utilizing creative metrics for quantifying clustering in
modification-specific sequencing experiments, we have confirmed that clusters of oxmCs can
occur in vitro. Although we were unable to definitively confirm whether TET can act
processively on multiple mCpGs on a single DNA strand, we obtained evidence to suggest
these clusters may be due to local sequence context preferences outside of the +1 base
(Chapter 4).
The analysis of steady-state products generated from these different substrates was
important, and it sets up crucial downstream experiments that can continue to refine the
understanding of TET enzymes. Therefore, in this Chapter, I propose two methods to test the
impact of specific reaction steps on the relative substrate preferences of TET. Also, I explore
ways in which our current knowledge of the intrinsic properties of TET enzymes can be
exploited towards the development of more efficient and specific epigenetic editing
complexes.
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5.1: Exploring the complexities of TET mechanistic pathways
To date, most of the biochemical experiments with TET enzymes quantify steady-state
activity. Single-turnover experiments and other kinetic measurements have likely not been
explored due to the complexity of the possible reaction steps of the full TET oxidation pathway
(Figure 5-1). As discussed previously, mC, hmC, and fC are each possible substrates and
they may be converted to product either through independent, distributive behavior (horizontal
pathways) or through an iterative mechanism (highlighted in blue). In this schema, TET is
depicted as maintaining the product-substrate flipped into the active site between chemical
conversions in the iterative pathway. However, crystal structure data of two different TET
homologs (hTET2 and NgTET1) bound to hmC or fC suggest that some conformational
change must occur to allow for the exchange of fresh cofactors, Fe(II) and α-ketoglutarate
(αKG) (Hashimoto et al., 2015; Hu, L. et al., 2015). Although this exchange may occur while
the extrahelical base remains in the active site, it is also possible that it flips back into the
duplex while TET maintains non-specific local contacts with DNA, until the target base flips
back into the active site for catalysis (Crawford et al., 2016). Even if the latter is not the case
the case for catalytic processivity, it remains a possible mechanism through which strand
processivity could occur. The nuances and interplay of these mechanisms likely contribute to
the difficulty in testing for strand processivity when assessing the steady-state products.
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Figure 5-1. Scheme of possible reaction steps for TET enzymes.
A simplified iterative/catalytically processive pathway is highlighted in blue. After
specific contact with a target modified cytosine is lost, the enzyme could either
dissociate completely (koff), suggesting activity is distributive, or could remain
non-specifically bound (koff,s). This could allow for strand processivity, mediating
TET to another target site of either mC, hmC, or fC, as indicated by red stars. ns,
non-specific; s, specific.
In order to fully understand the basis for and potentially exploit TET’s inherent
substrate preferences, it will be critical for the field to develop methods to test specific reaction
steps. Although the chemical reaction steps could be involved, studies of other DNA modifying
enzymes implicate mechanisms of substrate engagement in dictating their different substrate
preferences. The binding of most DNA-modifying enzymes to their target sites is thought to
include a minimum of three binding steps: binding to non-specific DNA, finding the target site,
and engaging the nucleotide in the active site (Hendershot and O'Brien, 2017). To achieve the
latter, all but one known DNA-modifying enzyme to date (DNA repair glycosylase AlkD)
employ nucleotide-flipping. It is less clear, however, how TET finds target sites and positions
itself for that reaction step. Nevertheless, I propose that measuring dissociation rates and the
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equilibrium constants for nucleotide-flipping of TET enzymes with various substrates will
illuminate the mechanisms regulating TET’s substrate preferences.
5.1.1: Measuring dissociation rates of TET enzymes from different substrates
Previously, binding affinities (KD) have been determined for TET2 on DNA. Human TET2CS exhibited nearly identical affinities for C-, mC-, hmC- and f-CpG-containing dsDNA, with KDs
of about 0.5-1µM (Hu, L. et al., 2015). The binding affinity of TET2 on mCpH-containing DNA, or
even mCpG-containing DNA embedded in a range of local sequence contexts, has not been
measured. It is generally assumed that TET enzymes also exhibit relatively similar affinities for
non-specific DNA because the majority of the protein-DNA contacts are between TET and the
phosphodiester backbone, but this assumption has not been proven. I am also interested in
comparing TET enzymes’ non-specific and mC-specific affinities with DNA versus RNA. In
particular, considering that TET2 exhibited such a strong preference for deoxribomethylcytosine,
it would be interesting if enhanced or diminished affinity for dmC over ribomethylcytosine
contributed to this mechanism.
Unfortunately, due to the current concentration limits of our recombinant protein
preparations, we are unable to generate complete equilibrium binding curves to calculate KDs. In
addition, the binding, searching, and the conformational rearrangements that ultimately result in
flipping are expected to be very rapid, occurring on a millisecond timescale (Hendershot and
O'Brien, 2017). Nevertheless, I have begun to address the potential role of substrate
engagement mechanisms in the preference for DNA over RNA by assessing the dissociation
rates of TET from different nucleic acid-TET complexes. While it is unknown at which point in the
possible substrate engagement pathway that the enzyme most likely to falls off DNA in our
simplified schema, measuring dissociation rates will allow us to examine nucleic acid preferences
broadly across the contributing reaction steps (Figure 5-2A).
To measure dissociation rates, I utilized the fluorescence anisotropy detection of a
stopped flow apparatus (Kintek). For these preliminary experiments, I used FAM-labeled versions
of the single-stranded 16mer DNA and RNA substrates, each containing a single mCpG, that I
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previously described in Chapter 2 (Figure 2-1A). These experiments were performed by first
forming TET2-DNA-/RNA-FAM complexes by incubating 1.1 µM TET2 with 100 nM of the FAMlabeled ssDNA or ssRNA probe (for 10-fold excess enzyme) for 1 hour at room temperature. The
buffer conditions were similar to those used in the majority of the biochemical experiments in this
thesis (50 mM HEPES, pH 6.5, 100 mM NaCl, 1 mM DTT, 2 mM sodium ascorbate, 75 µM
ammonium iron(II) sulfate), with the exception that 1 mM N-oxalylglycine (NOG), rather than αKG,
was used to inhibit catalysis. The addition of TET2 resulted in an increase in fluorescence
anisotropy, relative to that of the probe mixed with only buffer.
To initiate dissociation, the TET2:DNA-/RNA-FAM complexes were each rapidly mixed
with an equal volume of unlabeled versions of the DNA/RNA probes at 10 uM (18X excess)
(Figure 5-2B,C) and fluorescence anisotropy was measured for 1-3 min. Unfortunately, for both
the TET2:DNA-FAM and TET2:RNA-FAM complexes, these conditions were not sufficient to fully
dissociate the initial complexes after 60 seconds (Figure 5-2B-C) or up to 3 minutes (data not
shown). To calculate accurate koff values (or half-lives, t1/2, of the complexes), ideally the
dissociation curves would return to baseline. Nevertheless, I performed a follow-up experiment in
which I mixed the TET2:RNA-FAM complex with an excess of unlabeled DNA that contained
multiple mCpGs, rather than just one (Figure 5-2D). Interestingly, the TET2:RNA-FAM complex
exhibits enhanced dissociation in the presence of this multi-mCpG-containing DNA quench in the
first 60 seconds. Even after 15 minutes, the TET2:RNA-FAM complex had still not completely
dissociated, but it does exhibit a 2-fold change in anisotropy, similar to the scale of the change
observed with TET2:DNA-FAM in excess of the single mCG-DNA quench after 60 seconds. Thus,
these findings suggest that TET2 has a much slower off-rate from RNA compared to DNA.
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Figure 5-2. Fluorescence polarization can be used to measure the
dissociation rates of TET from different substrates.
A) Measured koff rates could reflect dissociation from any of these different levels
of substrate engagement (i.e., koff,obs). B-D) Curves represent the change in
anisotropy over time when pre-formed complexes of the catalytic domain of TET2
with either a DNA-FAM (B) or RNA-FAM probe (C,D) are rapidly mixed with
either just buffer or an excess of unlabeled quench substrate. The change in
anisotropy was calculated by subtracting the relative baseline measurement of
non-complexed DNA- or RNA-FAM probes mixed with buffer.
5.1.2: Proposal to investigate the role of nucleotide flipping in TET specificity
To further probe the mechanisms of substrate engagement regulating substrate
preference, I propose taking kinetic measurements of nucleotide-flipping. From the crystal
structures of TET homologs bound to DNA we know that TET engagement causes DNA
kinking and the nearly 180° rotation of the target mC nucleotide out of the DNA duplex and
into the active site of TET. As mentioned, this is a common mechanism for nearly all DNAmodifying enzymes. However, the specific steps that proceed this action can vary for different
enzymes. For example, there is some evidence to suggest Uracil DNA glycosylase (UDG)
engages with extrahelical bases as they spontaneously emerge from duplex DNA via thermal
fluctuations during its search for lesions. However, there has also been evidence suggesting that
UDG intentionally samples different nucleotides in order to find lesions. Many of the DNAmodifying proteins likely combine these two mechanisms. For example, TDG is thought to
precipitate the extrusion of the target base from the duplex and then capture it in the active site;
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however, it too is thought to be aided by the fluctuations of G:fC and G:caC base pairs in its
ability to fully flip these targets into the active site (Dai et al., 2016; Maiti et al., 2013).
From structural and biochemical data, I have speculated how different substrates can
impact the substrate engagement reaction steps. First, because TET has exhibited robust activity
in single-stranded DNA, contacts with the opposite strand of duplexed DNA are likely not
necessary for the torsion of the DNA required for nucleotide flipping. With regards to both the
preference for DNA over RNA and tolerance for hmCpH, there appears to be some relationship
between the strength of the interactions with the phosphodiester backbone surrounding the target
base and either the strength of base-stacking or helical conformation. Although it would prove
informative to test each of the involved reaction steps in substrate engagement if possible, I
believe studying the relative occupancy of TET with a flipped-out target nucleotide when bound to
substrate DNA will be the most informative to begin with.
Recently, colleagues at the University of Maryland have used 19F 1D NMR to study the
role of nucleotide flipping in TDG specificity (Dow et al., 2019). 19F, which is hypersensitive to its
local environment, allows for a much greater range of chemical shifts than the corresponding 1H
nuclei. By embedding target nucleotides that contain 19F at the 2’-position, they were able to
measure the distinct chemical shifts resulting from distinct chemical environments, reflecting
occupancies of the nucleotide in different positions; specifically, whether stacked in the duplex or
flipped into the TDG active site.
In this study, the authors compared the peak shifts for free versus TDG-bound T(19F)containing DNA, when the T(19F) is base-paired with either a mismatched G or the canonical A.
These experiments were performed 1000-fold above the KD of TDG with non-specific DNA, thus
operating under the assumption that TDG is stably bound to DNA. The T•G-DNA exhibits two
NMR peaks when bound to TDG, suggesting that the 2’-19F occupies two distinct chemical
environments, one where the base remains stacked in the DNA duplex (Istacked) and the other
where the base is flipped into the active site of TDG (Iflipped). In contrast, T•A-DNA exhibits a
single NMR peak when bound to TDG, with the same chemical shift as free DNA. Equilibrium
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constants for reversible nucleotide flipping (Kflip) are calculated for both conditions by taking the
ratio of the intensity of the two relative peaks (Iflipped/Istacked) (Figure 5-3A).

Figure 5-3. 19F NMR can be used to measure the propensity for nucleotide
flipping.
A) The peak shifts in 19F 1D NMR correspond to when the 19F-containing
nucleotide is either “stacked” in the DNA helix (left) or “flipped” into the active site
of the enzyme. The nucleotide flipping equilibrium constant (Kflip) is calculated
as the ratio of these two respective peak intensities (Iflipped/Istacked) B) The 19Fcontaining nucleotide can be synthesized in either the 2’-F-ribo or 2’-F-arabino
conformations.
In collaboration with our colleagues, we are thus poised to ask about the relative
nucleotide flipping of TDG, but also TET, with fC(19F)-containing DNA which has already been
synthesized. Although it would be ideal to also analyze TET nucleotide flipping with mC and hmC,
the synthesis can be cumbersome. Nevertheless, using fC(19F)-substrates could still provide
insight into the mechanisms dictating the CpG versus CpH preference of TET, since in Chapter 3,
we observe a similar difference in the relative ratios of activity for fCpG versus fCpH substrates
as we do with those with mCpG versus mCpH. The 19F-containing substrates in the published
TDG experiments contain 2’-F-arabino, which is compatible with B-form DNA. However, 2’-F-ribo
forms, which are compatible with A-form RNA, of the modified cytosine nucleotides could also be
generated (Figure 5-3B). Experiments with these different target nucleotides embedded in either
DNA or RNA strands could specifically test the role of nucleotide flipping in our proposed model
of DNA versus RNA specificity in Chapter 2.
In summary, I propose that the next logical expansion of the work in this thesis is to test
the proposed mechanisms that may be dictating TET substrate specificity. Both of these
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approaches, either examining KDs/off-rates or nucleotide flipping, require greater concentrations
of protein than our current expression and purification methods currently allow. Other members of
the lab have been working towards the goal of making more concentrated, active TET proteins in
an E. coli rather than insect cell expression system. Nevertheless, I anticipate that insights gained
in this thesis, as well as those proposed in this section, are critical for towards the overarching
goal of being able to interpret the biological purpose of TET’s varied activity preferences, as well
as for the development of optimal epigenetic editing tools.
5.2: Exploring the future of epigenome editing
This section of the chapter was adapted from parts of the following review article:
DeNizio, J.E., Schutsky, E.K., Berrios, K., Liu, M.Y., Kohli, R.M. Harnessing natural DNA
modifying activities for editing of the genome and epigenome. Curr. Opin. Chem. Biol. 2018, 45,
10-17.
5.2.1: Introduction to editing complexes
The introduction of site-specific DNA modifications to the genome or epigenome presents
great opportunities for manipulating biological systems. Such changes are now possible through
the combination of DNA-modifying enzymes with targeting modules, including dCas9, that can
localize the enzymes to specific sites, potentially enabling more direct accounting of cause and
effect at specific loci. Although the effect of targeted DNA methylation on downregulating gene
expression is variable and often modest, there is stronger evidence that the demethylation of a
specific loci can result in gene activation (Lei et al., 2018). Nevertheless, there are still many
unknowns prohibiting the effective use of these tools, such as: which loci are regulated by DNA
methylation? If they are, how many mCpGs in which regulatory regions need to be demethylated
to achieve phenotypic changes? And, what factors are regulating the demethylation of these
mCpGs? I anticipate that the exploitation of the intrinsic features of TET enzymes, particularly
with regards to clustering capacity and substrate specificity, will prove critical towards advancing
this technology. In this section, I will review how TET enzymes, as well as other DNA modifying
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enzymes, have been utilized in the past and propose new alternatives to how they can be used in
the future, highlighting ways in which they can enhance both editing efficiency and/or specificity.
To provide a framework for understanding these methodological developments, we offer
a generic definition of the editing complexes (Figure 5-4). The typical formula for an editing
complex involves a DNA targeting module (TM) partnered with one or more DNA modifying
modules (MM). The TMs can recognize specific nucleotide sequences including certain modified
bases within those sequences. MMs can be partnered with accessory modules (MMX) or can be
variants of the natural enzyme with altered biochemical properties (MM*) or with tunable activity
(MM†).

Figure 5-4. A formulaic approach for assessing current epigenetic editing
complexes and proposing new advances.
Editing complexes can be described as consisting of a Targeting Module (TM)
and Modifying Module (MM), which can be classified based on other
distinguishing features, including the addition of accessory modules (MMX),
variants of the native enzymes with altered activities (MM*), or tunable variants
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with altered spatiotemporal control (MM†). Established examples of these
complexes are shown, as well as anticipated advances based on the knowledge
of the structure and function of TET enzymes. Lines connecting the modules
represent fusions or linkers, and a plus sign indicates that the two relative entities
were co-expressed separately. The dashed line indicates that both fused and
unfused/co-expressed versions have been made.
While potential TMs have been well reviewed recently (Hu, J. H. et al., 2016; Nelson and
Gersbach, 2016), I will briefly note the available constructs to frame our discussion of DNAmodifying enzymes. The original method for programmable targeting of DNA sequences
employed zinc-finger proteins (ZFPs) which recognize a trinucleotide motif and can be
concatenated to recognize longer stretches of DNA (Gersbach et al., 2014). The discovery of
transcription activator-like effector (TALE) proteins from plant pathogens later offered a means for
targeting single bases, and, like with ZFPs, concatenation of TALEs results in selective
recognition of longer DNA motifs (Joung and Sander, 2013). Structure-function insights into the
TALE residues that contact nucleobases have permitted the development of constructs that
differentiate unmodified cytosine from 5mC and ox-mCs (Kubik et al., 2015; Maurer et al., 2016;
Rathi et al., 2017; Zhang, Y. et al., 2017). Such modified TMs (TM*) have not yet been employed
with different MMs, but the combination would make for a logical and anticipated advance. While
ZFPs and TALEs are still being employed, the CRISPR/Cas system offers a more adaptable
solution to the challenges of designing TMs, in that different guide RNAs (gRNA) could be used to
achieve targeting to multiple locations with a single protein scaffold, rather than having to
manipulate individual proteins for each target. Although Cas9 was originally exploited for targeted
DNA cleavage, using catalytically inactive Cas9 (dCas9) or nicking variants (nCas9) allows for
retention of localization capabilities and partnering with DNA-modifying enzymes as MMs. The
discovery of new CRISPR/Cas systems will likely expand the TM choices yet further (Makarova et
al., 2015). Across the variety of combinations, TM and MMs can be directly fused, which requires
optimization of module ordering and linker lengths, or can be brought together by exploiting
protein-protein or protein-RNA interactions (in the case of Cas9) to promote co-localization.
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5.2.2: Strategies towards efficient levels of targeted TET oxidation
Due to the varied nature of TET homologs, there are many opportunities to utilize
naturally occurring homologs as MMs that could possibly yield efficient editing. With regards to
the human homologs, one study utilized the catalytic domains of TET1, TET2, and TET3 and
observed the greatest demethylation efficiency with TET2. Despite this, TET1, coupled to ZFPs,
TALEs, and more commonly now to dCas9 (Chen, H. et al., 2014; Choudhury et al., 2016; Liu, X.
S. et al., 2016; Lo et al., 2017; Maeder et al., 2013; Morita et al., 2016; Xu, X. et al., 2016), is
most frequently employed. Intriguingly, plants have a direct demethylation pathway through the
protein ROS1, a DNA glycosylase that directly excises 5mC. After fusion with a yeast Gal4-DNA
binding domain as a TM, ROS1 has also been employed for direct demethylation and specific
reactivation of silenced genes (Parrilla-Doblas et al., 2017). The ROS1 construct represents the
concept of using a native MM out of its native context, and such strategies might be more
generally employed; for example, the well-behaved NgTET1 (Hashimoto, Pais et al., 2014;
Hashimoto et al., 2015) could be employed instead of mammalian TET enzymes.
Additionally, partnering of native proteins to accessory modules (MMX) can be used to
enhance editing. The initial groundbreaking effort for genome editing employed APOBEC1, which
is a single-stranded DNA deaminase that catalyzes a C>U transition, as the MM, along with
dCas9, which plays a dual role in targeting and in unwinding of the target site so that APOBEC1
may access a ssDNA substrate. With this construct, in cis incorporation of the accessory protein
UGI – a small phage-derived protein that potently inhibits UDG – prevents downstream repair and
greatly increases the efficiency of editing processes (Komor et al., 2016). This idea has also been
applied to epigenome editing: fusing DNMT3L as an MMX to DNMT3A enables multimerization
and promotes processive methylation, which potentially helps replicate the natural tendency of
methylation clustering (Stepper et al., 2017). It is feasible that the MMX approach could be
extended in the future by combining multiple MMs in cis; for example, locus-specific
demethylation could be enhanced by fusing TDG to TET-containing constructs.
There are several factors that have been shown to influence the range of activity of a MM
surrounding a targeted region. For example, distance from the sgRNA anchoring site when the
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TM is dCas9, linker length between the TM and MM, and size of the chosen MM have all been
shown to influence the distances over which epigenetic DNA editing is observed (Lei et al., 2018).
Similar to the effect seen by fusing DNMT3L as an MMX (Huang, Y. H. et al., 2017), the SunTag
system has been employed to expand the range of activity. This system relies on multiple
antibody epitopes that can be recognized by a single-chain variable fragment (scFv). Fusing
dCas9 with the epitopes and the MM to the scFv can result in multiple proteins being targeted to
the designated locus, amplifying the activity (Huang, Y. H. et al., 2017; Morita et al., 2016).
Attaching a TET enzyme to the SunTag system has resulted in several instances in which
demethylation was more efficiently spread over a region (Gallego-Bartolome et al., 2018; Morita
et al., 2016). Although it will likely be loci specific, the number of SunTags could also manipulated
in order to control the number of TET proteins recruited, potentially allowing for control of the
relative range that gets oxidized. Theoretically, this level of control could help identify the minimal
regions of oxidation necessary for gene activation. To a similar end, if the strand processivity of a
particular TET homolog could be enhanced, via mutation enhancement or an interacting protein,
we may further amplify the demethylation efficiency or gene activation.
5.2.3: Harnessing intrinsic TET preferences for specific editing
Aside from harnessing native enzymes, existing structure-function knowledge has been
exploited to generate variants of DNA-modifying enzymes with increased specificity. Both rational
and screening-based approaches have been utilized to assess and/or evolve activities, with the
most significant advances coming in genome editing rather than epigenome editing thus far. For
example, prior biochemical work isolated sequence determinants of activity for each
AID/APOBEC family member (Kohli et al., 2010), and targeted alteration to this region and others
in the active site permitted increased precision in base editing (Kim et al., 2017).
Meanwhile, this thesis has demonstrated that TET enzymes, at least in vitro, can exhibit
relatively promiscuous activity, particularly on different nucleic acid structures. TET has only been
targeted to DNA thus far, but it is important to consider that RNA oxidation may be occurring and
confounding the phenotypic interpretation of the desired DNA editing. Although not relevant to
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dcas9 scaffolds, several other classes of Cas systems have been shown to facilitate RNAdependent RNA targeting (Cox et al., 2017; Strutt et al., 2018). As we learn more about the
different Cas systems and different ones are employed, this may become more of an issue,
necessitating the use of a TET mutant with diminished RNA activity. Further, current TETtargeting epigenetic editing systems do not have the specificity to allow us to ascertain the
independent roles of oxmCs both in vitro and in vivo, as all three TET isozymes are known to
make all three ox-mCs. Recently discovered hmC-dominant mutants of human TET2 (Liu, M. Y.
et al., 2017) or NgTET1 (Hashimoto et al., 2015), or a TET homolog from the mushroom C.
cinerea that produces mostly fC (Zhang, L. et al., 2014), could be utilized in editing systems to
more directly dissect the roles of individual oxmCs.
Lastly, systems within which TET activity can be spatiotemporally regulated to minimize
expression could prove advantageous for improving specificity. Splitting Cas9 to create a liganddependent activation variant has been an effective means to gain spatiotemporal control over
TMs (Oakes et al., 2016), an analogous protein-driven method for controlling MMs is to split the
relevant enzyme so that it only reconstitutes at the desired site. A recent study using a split
methyltransferase fused to dCas9 exhibited high specificity to target sites and suggested that the
strategy limited off-target effects (Xiong et al., 2017). Although not yet attached to a targeting
scaffold, TET2 has also been split and placed under the control of a small molecule modulator:
Two inactive fragments were individually fused with either FKBP12 or FRB, and upon the addition
of rapamycin, TET2 reassembled into a functional enzyme (Lee, M. et al., 2017). Another method
for control involves tagging the MM, such as TET1, with the RNA-binding protein MS2, which is
directed to dCas9 by incorporation of MS2 hairpin-binding sites into the gRNA (Hess et al., 2016;
Xu, X. et al., 2016).
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